Benefitfocus (BNFT) 10-Q 8 Nov 22 2022 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Nov. 04, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Registrant Name	Benefitfocus, Inc.
Entity Central Index Key	0001576169
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		34,420,618
Title of 12(b) Security	Common Stock, $0.001 Par Value
Trading Symbol	BNFT
Entity Incorporation, State or Country Code	DE
Security Exchange Name	NASDAQ
Entity File Number	001-36061
Entity Tax Identification Number	46-2346314
Entity Address, Address Line One	100 Benefitfocus Way
Entity Address, City or Town	Charleston
Entity Address, State or Province	SC
Entity Address, Postal Zip Code	29492
City Area Code	843
Local Phone Number	849-7476
Document Quarterly Report	true
Document Transition Report	false

Unaudited Consolidated Balance

Unaudited Consolidated Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 55,124,000	$ 31,001,000
Marketable securities	0	37,049,000
Accounts receivable, net	27,598,000	16,491,000
Contract, prepaid and other current assets	18,307,000	27,615,000
Total current assets	101,029,000	112,156,000
Property and equipment, net	24,728,000	27,202,000
Financing lease right-of-use assets	48,445,000	56,474,000
Operating lease right-of-use assets	615,000	774,000
Intangible assets, net	17,915,000	21,134,000
Goodwill	34,237,000	34,237,000
Deferred contract costs and other non-current assets	6,744,000	8,864,000
Total assets	233,713,000	260,841,000
Current liabilities:
Accounts payable	6,064,000	10,565,000
Accrued expenses	7,552,000	9,451,000
Accrued compensation and benefits	15,208,000	16,411,000
Deferred revenue, current portion	30,443,000	27,756,000
Long-term debt, current portion	5,186,000	0
Lease liabilities and financing obligations, current portion	6,607,000	7,378,000
Contingent consideration	0	675,000
Total current liabilities	71,060,000	72,236,000
Deferred revenue, net of current portion	2,364,000	2,377,000
Convertible senior notes	6,836,000	107,281,000
Long-term debt, net of current portion	105,349,000	0
Lease liabilities and financing obligations, net current portion	72,581,000	75,758,000
Other non-current liabilities	392,000	313,000
Total liabilities	258,582,000	257,965,000
Commitments and contingencies
Redeemable preferred stock:
Series A preferred stock, par value $0.001, 5,000,000 shares authorized, 1,777,778 and 1,777,778 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively, liquidation preference $45 per share as of September 30, 2022 and December 31, 2021, respectively	79,193,000	79,193,000
Stockholders' deficit:
Common stock, par value $0.001, 95,000,000 shares authorized, 34,392,269 and 33,460,545 issued and outstanding at September 30, 2022 and December 31, 2021, respectively	34,000	33,000
Additional paid-in capital	384,886,000	431,874,000
Accumulated deficit	(488,982,000)	(508,224,000)
Total stockholders' deficit	(104,062,000)	(76,317,000)
Total liabilities, redeemable preferred stock and stockholders' deficit	$ 233,713,000	$ 260,841,000

Unaudited Consolidated Balanc_2

Unaudited Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	1,777,778	1,777,778
Preferred stock, shares outstanding	1,777,778	1,777,778
Liquidation preference per share	$ 45	$ 45
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	95,000,000	95,000,000
Common stock, shares issued	34,392,269	33,460,545
Common stock, shares outstanding	34,392,269	33,460,545

Unaudited Consolidated Statemen

Unaudited Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenue	$ 56,190	$ 62,026	$ 174,002	$ 187,993
Cost of revenue	29,864	31,247	88,845	87,870
Gross profit	26,326	30,779	85,157	100,123
Operating expenses:
Sales and marketing	10,029	12,669	30,596	34,481
Research and development	12,376	11,062	35,782	32,997
General and administrative	10,455	12,156	33,261	35,589
Impairment of lease right-of-use assets	0	0	1,769	4,003
Change in fair value of contingently returnable consideration	0	0	(719)	0
Restructuring costs	0	0	1,006	4,127
Total operating expenses	32,860	35,887	101,695	111,197
Loss from operations	(6,534)	(5,108)	(16,538)	(11,074)
Other income (expense):
Interest income	223	52	307	163
Interest expense	(2,918)	(5,556)	(7,876)	(16,757)
Gain (loss) on repurchase of convertible senior notes	1,930	(7,520)	1,930	(7,520)
Other income	362	120	844	142
Total other expense, net	(403)	(12,904)	(4,795)	(23,972)
Loss before income taxes	(6,937)	(18,012)	(21,333)	(35,046)
Income tax expense	49	42	94	125
Net loss	(6,986)	(18,054)	(21,427)	(35,171)
Preferred dividends	(1,600)	(1,600)	(4,800)	(4,800)
Net loss available to common stockholders	(8,586)	(19,654)	(26,227)	(39,971)
Comprehensive loss	$ (6,986)	$ (18,054)	$ (21,427)	$ (35,171)
Net loss per common share, basic:
Basic	$ (0.25)	$ (0.59)	$ (0.77)	$ (1.21)
Net loss per common share, diluted:
Diluted	$ (0.25)	$ (0.59)	$ (0.77)	$ (1.21)
Weighted-average common shares outstanding, basic:
Basic	34,279,464	33,354,624	33,937,778	32,978,394
Weighted-average common shares outstanding, diluted:
Diluted	34,279,464	33,354,624	33,937,778	32,978,394

Unaudited Consolidated Statem_2

Unaudited Consolidated Statements of Changes in Stockholders' Deficit - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock, $0.001 Par Value	Common Stock, $0.001 Par Value Cumulative Effect, Period of Adoption, Adjustment	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Balance at Dec. 31, 2020	$ (48,595)		$ 32		$ 427,431		$ (476,058)
Balance (in shares) at Dec. 31, 2020			32,327,439
Exercise of stock options	155		$ 1		154		0
Exercise of stock options (in shares)			15,000
Issuance of common stock upon vesting of restricted stock units	0		$ 0		0		0
Issuance of common stock upon vesting of restricted stock units (in shares)			173,731
Stock-based compensation expense	1,523		$ 0		1,523		0
Preferred dividends	(1,600)		0		(1,600)		0
Net loss	(2,097)		0		0		(2,097)
Balance at Mar. 31, 2021	(50,614)		$ 33		427,508		(478,155)
Balance (in shares) at Mar. 31, 2021			32,516,170
Balance at Dec. 31, 2020	(48,595)		$ 32		427,431		(476,058)
Balance (in shares) at Dec. 31, 2020			32,327,439
Net loss	(35,171)
Balance at Sep. 30, 2021	(81,218)		$ 33		429,978		(511,229)
Balance (in shares) at Sep. 30, 2021			33,386,994
Balance at Dec. 31, 2020	(48,595)		$ 32		427,431		(476,058)
Balance (in shares) at Dec. 31, 2020			32,327,439
Balance at Dec. 31, 2021	$ (76,317)		$ 33		431,874		(508,224)
Balance (in shares) at Dec. 31, 2021	33,460,545		33,460,545
Balance at Mar. 31, 2021	$ (50,614)		$ 33		427,508		(478,155)
Balance (in shares) at Mar. 31, 2021			32,516,170
Exercise of stock options	102		$ 0		102		0
Exercise of stock options (in shares)			9,250
Issuance of common stock upon vesting of restricted stock units	0		$ 0		0		0
Issuance of common stock upon vesting of restricted stock units (in shares)			704,543
Issuance of common stock under Employee Stock Purchase Plan, or ESPP	65		$ 0		65		0
Issuance of common stock under Employee Stock Purchase Plan, or ESPP (in shares)			4,823
Stock-based compensation expense	4,376		$ 0		4,376		0
Preferred dividends	(1,600)		0		(1,600)		0
Net loss	(15,020)		0		0		(15,020)
Balance at Jun. 30, 2021	(62,691)		$ 33		430,451		(493,175)
Balance (in shares) at Jun. 30, 2021			33,234,786
Issuance of common stock upon vesting of restricted stock units	0		$ 0		0		0
Issuance of common stock upon vesting of restricted stock units (in shares)			152,208
Cancellation of convertible senior note capped call hedge	98		$ 0		98		0
Cancellation of convertible senior note capped call hedge (in shares)			0
Equity component of repurchased convertible senior notes	(3,566)		$ 0		(3,566)		0
Stock-based compensation expense	4,595		0		4,595		0
Preferred dividends	(1,600)		0		(1,600)		0
Net loss	(18,054)		0		0		(18,054)
Balance at Sep. 30, 2021	(81,218)		$ 33		429,978		(511,229)
Balance (in shares) at Sep. 30, 2021			33,386,994
Balance at Dec. 31, 2021	$ (76,317)		$ 33		431,874		(508,224)
Balance (in shares) at Dec. 31, 2021	33,460,545		33,460,545
Cumulative effect adjustment from adoption of new accounting standard at Dec. 31, 2021		$ (12,304)		$ 0		$ (52,973)		$ 40,669
Issuance of common stock upon vesting of restricted stock units	$ 0		$ 0		0		0
Issuance of common stock upon vesting of restricted stock units (in shares)			60,572
Stock-based compensation expense	1,189		$ 0		1,189		0
Preferred dividends	(1,600)		0		(1,600)		0
Net loss	(2,277)		0		0		(2,277)
Balance at Mar. 31, 2022	(91,309)		$ 33		378,490		(469,832)
Balance (in shares) at Mar. 31, 2022			33,521,117
Balance at Dec. 31, 2021	$ (76,317)		$ 33		431,874		(508,224)
Balance (in shares) at Dec. 31, 2021	33,460,545		33,460,545
Cumulative effect adjustment from adoption of new accounting standard at Dec. 31, 2021		$ (12,304)		$ 0		$ (52,973)		$ 40,669
Net loss	$ (21,427)
Balance at Sep. 30, 2022	$ (104,062)		$ 34		384,886		(488,982)
Balance (in shares) at Sep. 30, 2022	34,392,269		34,392,269
Balance at Mar. 31, 2022	$ (91,309)		$ 33		378,490		(469,832)
Balance (in shares) at Mar. 31, 2022			33,521,117
Issuance of common stock upon vesting of restricted stock units	0		$ 1		(1)		0
Issuance of common stock upon vesting of restricted stock units (in shares)			650,962
Stock-based compensation expense	5,315		$ 0		5,315		0
Preferred dividends	(1,600)		0		(1,600)		0
Net loss	(12,164)		0		0		(12,164)
Balance at Jun. 30, 2022	(99,758)		$ 34		382,204		(481,996)
Balance (in shares) at Jun. 30, 2022			34,172,079
Issuance of common stock upon vesting of restricted stock units	0		$ 0		0		0
Issuance of common stock upon vesting of restricted stock units (in shares)			212,265
Issuance of common stock under Employee Stock Purchase Plan, or ESPP	58		$ 0		58		0
Issuance of common stock under Employee Stock Purchase Plan, or ESPP (in shares)			7,925
Cancellation of convertible senior note capped call hedge	6		$ 0		6		0
Cancellation of convertible senior note capped call hedge (in shares)			0
Stock-based compensation expense	4,218		$ 0		4,218		0
Preferred dividends	(1,600)		0		(1,600)		0
Net loss	(6,986)		0		0		(6,986)
Balance at Sep. 30, 2022	$ (104,062)		$ 34		$ 384,886		$ (488,982)
Balance (in shares) at Sep. 30, 2022	34,392,269		34,392,269

Unaudited Consolidated Statem_3

Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net loss	$ (21,427)	$ (35,171)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	19,955	18,976
Stock-based compensation expense	10,722	10,494
Accretion of interest on convertible senior notes	507	8,590
Interest accrual on finance lease liabilities	19	3,259
Rent expense less than payments	(82)	(41)
Change in fair value of contingently returnable assets	719	0
Non-cash accretion income from investments	29	741
Amortization of debt issuance costs	58	0
Impairment or loss on disposal of right-of-use assets and property and equipment	1,769	4,074
Gain (loss) on extinguishment of debt	(1,930)	7,520
Changes in operating assets and liabilities:
Accounts receivable, net	(11,107)	1,872
Accrued interest on investments	284	161
Contract, prepaid and other current assets	9,591	4,009
Deferred costs and other non-current assets	2,493	1,238
Accounts payable and accrued expenses	(5,696)	6,960
Accrued compensation and benefits	(1,203)	(2,136)
Deferred revenue	2,674	(3,441)
Other non-current liabilities	80	191
Net cash provided by operating activities	6,017	27,296
Cash flows from investing activities
Purchases of investments held-to-maturity	0	(91,361)
Proceeds from short-term investments held-to-maturity	0	100,588
Maturities of investments available-for-sale	22,045	0
Sales of investments available-for-sale	14,691	0
Business combination, net of cash acquired	(500)	0
Purchases of property and equipment	(6,116)	(7,454)
Net cash provided by investing activities	30,120	1,773
Cash flows from financing activities
Proceeds from long-term debt	112,000	0
Repurchase of convertible senior notes	(111,628)	(98,678)
Payments of debt issuance costs	(1,841)	0
Cancellation of convertible senior notes capped call hedge	6	98
Payments of preferred dividends	(4,800)	(4,800)
Proceeds from contingently returnable consideration	879	0
Payments of contingent consideration	(675)	0
Proceeds from exercises of stock options and ESPP	58	322
Payments on financing obligations	(327)	(226)
Payments of principal on finance lease liabilities	(5,686)	(3,902)
Net cash used in financing activities	(12,014)	(107,186)
Net increase (decrease) in cash and cash equivalents	24,123	(78,117)
Cash and cash equivalents, beginning of period	31,001	90,706
Cash and cash equivalents, end of period	55,124	12,589
Supplemental disclosure of non-cash investing and financing activities
Property and equipment purchases in accounts payable and accrued expenses	0	945
Debt issuance costs included in accounts payable and accrued expenses	$ 53	$ 0

Organization and Description of

Organization and Description of Business	9 Months Ended
	Sep. 30, 2022
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business Benefitfocus, Inc. (the “Company”) provides a leading cloud-based benefits management platform for consumers, employers, health plans (also known as insurance carriers) and brokers that is designed to simplify how organizations and individuals transact benefits. The financial statements of the Company include the financial position and operations of its wholly owned subsidiaries, Benefitfocus.com, Inc., BenefitStore, LLC (formerly, BenefitStore, Inc.) and Tango Health, Inc.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Principles of Consolidation These consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in the consolidation. The Company is not the primary beneficiary of, nor does it have a controlling financial interest in, any variable interest entity. Accordingly, the Company has not consolidated any variable interest entity. Interim Unaudited Consolidated Financial Information The accompanying unaudited consolidated financial statements and footnotes have been prepared in accordance with GAAP as contained in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (the “Codification” or “ASC”) for interim financial information, and with Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all adjustments of a normal recurring nature necessary for a fair presentation of the results of operations and comprehensive loss, financial position, changes in stockholders’ deficit and cash flows. The results of operations and comprehensive loss for the three- and nine-month periods ended September 30, 2022 are not necessarily indicative of the results for the full year or for any other future periods. These unaudited consolidated financial statements should be read in conjunction with the audited financial statements and related footnotes for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, as amended. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Such estimates include allowances for credit losses and returns, valuations of deferred income taxes, long-lived assets, capitalizable software development costs and the related amortization, contingent consideration, incremental borrowing rate used in lease accounting, the determination of the useful lives of assets, and the impairment assessment of right-of-use assets, acquired intangibles and goodwill. Additionally, as described in revenue and deferred revenue below, estimates are utilized in association with revenue recognition, in particular the estimation of variable consideration using the expected value method from insurance broker commissions reported in Platform revenue. Determination of these transactions and account balances are based on, among other things, the Company’s estimates and judgments. These estimates are based on the Company’s knowledge of current events and actions it may undertake in the future as well as on various other assumptions that it believes to be reasonable. Actual results could differ materially from these estimates. Restructuring Costs Restructuring costs are comprised of one-time severance charges, continuation of health benefits and outplacement services and are presented separately in operating expenses in the consolidated statements of operations and comprehensive loss. The Company recorded restructuring costs of $ 1,006 and $ 1,400 from a reduction to its workforce during January 2022 and 2021, respectively. In June 2021, the Company recorded restructuring costs of $ 2,727 from the elimination of the office of the executive chairman of the Board of Directors. Revenue and Deferred Revenue The Company derives its revenue primarily from fees for subscription services and professional services sold to employers and health plans as well as platform revenue derived from the value of products sold on its platform. Revenue is recognized when control of these services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Taxes collected from customers relating to services and remitted to governmental authorities are excluded from revenue. The Company determines revenue recognition through the following steps: • Identification of each contract with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, performance obligations are satisfied. Software Services Revenue Software services revenue consists of subscription revenue and platform revenue. Subscription Revenue Subscription revenue primarily consists of monthly or annual subscription fees paid to the Company by its employer and health plan customers for access to, and usage of, cloud-based benefits software solutions for a specified contract term. Fees are generally charged based on the number of employees or subscribers with access to the solution. Subscription services revenue is generally recognized on a ratable basis over the contract term beginning on the date the subscription services are made available to the customer. The Company’s subscription service contracts are generally three years. Subscription revenue also includes fees paid for other services, such as event sponsorships and certain data services. Platform Revenue Platform revenue is generated from the value of policies or products enrolled in through the Company’s marketplace. Platform revenue from insurance carriers is generally recognized over the policy period of the enrolled products. In arrangements where the Company sells policies to employees of its customers as the broker, it earns broker commissions. Revenue from insurance broker commissions and supplier transactions is recognized at a point in time when the orders for the policies are received and transferred to the insurance carrier or supplier and is reduced by constraints for variable consideration associated with collectability, policy cancellation and termination risks. Professional Services Revenue Professional services revenue primarily consists of fees related to the implementation of software products purchased by customers. Professional services typically include discovery, configuration and deployment, integration, testing, and training. Fees from consulting services and support services are also included in professional services revenue. The Company determined that implementation services for certain of its health plan customers significantly modify or customize the software solution and, as such, do not represent a distinct performance obligation. Accordingly, revenue from such implementation services with these health plan customers are generally recognized over the contract term of the associated subscription services contract, including any extension periods representing a material right. In certain arrangements, the Company utilizes estimates of hours as a measure of progress to determine revenue. Revenue from implementation services with employer customers is generally recognized as those services are performed. Revenue from support is recognized over the service period. Contracts with Multiple Performance Obligations Certain of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the individual performance obligations are accounted for separately if they are distinct. The Company allocates the transaction price to the separate performance obligations based on their relative standalone selling prices. The Company determines the standalone selling prices based on its overall pricing objectives, taking into consideration market conditions and other factors, including the value of its contracts, the subscription services sold, customer size and complexity, and the number and types of users under the contracts. Contract Costs The Company capitalizes costs to obtain contracts that are considered incremental and recoverable, such as sales commissions. Payments of sales commissions generally include multiple payments. The Company capitalizes only those payments made within an insignificant time from the contract inception, typically three months or less. Subsequent payments are expensed as incurred. The capitalized costs are amortized to sales and marketing expense over the estimated period of benefit of the asset, which is generally four to five years . The Company expenses the costs to obtain a contract when the amortization period is less than one year. Capitalized fulfillment costs are reviewed for impairment if changes to customer contracts result in termination or partial termination of services. Deferred costs related to obtaining contracts are included in deferred contract costs and other non-current assets. The Company capitalizes contract fulfillment costs directly associated with customer contracts that are not related to satisfying performance obligations. The costs are amortized to cost of revenue expense over the estimated period of benefit, which is generally five years . Deferred fulfillment costs are included in deferred contract costs and other non-current assets. The following tables present information about deferred contract costs: Balance of deferred contract costs As of As of Costs to obtain contracts $ 3,190 $ 4,418 Costs to fulfill contracts $ 1,678 $ 2,887 Three Months Ended September 30, Nine Months Ended September 30, Amortization of deferred contract costs 2022 2021 2022 2021 Costs to obtain contracts included in sales and marketing expense $ 593 $ 753 $ 1,836 $ 2,276 Costs to fulfill contracts included in cost of revenue $ 207 $ 308 $ 686 $ 998 Cost of Revenue Cost of revenue primarily consists of employee compensation, professional services, data center co-location costs, networking expenses, depreciation expense for computer equipment directly associated with generating revenue, amortization expense for capitalized software development costs, amortization of acquired intangibles, and infrastructure maintenance costs. In addition, the Company allocates a portion of overhead, such as facilities and security costs, additional depreciation and amortization expense, and employee benefit costs to cost of revenue based on headcount. Cash and Cash Equivalents Cash and cash equivalents consist of bank checking accounts and money market accounts. The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents . Restricted Cash Restricted cash consists of voluntary benefits premiums collected by the Company from its customer members. Restricted cash amounts are segregated in separate bank accounts and are used exclusively for the payment of the related amounts due to third-party insurance providers for benefits enrolled in by customer members. This usage restriction is contractually imposed and reflects the Company’s intention with regards to such deposits. Restricted cash was de minimis as of September 30, 2022 and there was no restricted cash as of December 31, 2021 . Marketable Securities Marketable securities consist of short-term investments in corporate bonds, commercial paper, and U.S. Treasury and agency bonds. During the year ended December 31, 2021, the Company changed the classification of its marketable securities from held-to-maturity to available-for-sale based on its intent to sell the securities. The Company’s available-for-sale marketable securities are recorded at fair value which approximates cost due to the short duration of such securities. Debt securities classified as either available-for-sale or held-to-maturity are subject to the expected credit loss model prescribed under Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments”. The Company utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for debt securities at the time the financial asset is originated or acquired. The Company measures expected credit losses on its debt portfolio on a collective basis by major security type. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. The Company’s credit loss calculations for debt securities are based upon historical default and recovery rates of bonds rated with the same rating as its portfolio. An adjustment factor is applied to these credit loss calculations based upon the Company’s assessment of the expected impact from current economic conditions on its investments. The Company monitors the credit quality of debt securities through the use of their respective credit rating and updates them on a quarterly basis. The allowance for credit losses is discussed in Note 7. Insurance Recovery The Company and several other defendants were involved with a legal proceeding regarding a complaint filed by the City of Pittsburgh Comprehensive Municipal Pension Trust Fund in the Supreme Court of the State of New York, County of New York (the “Court”). The complaint asserted claims on behalf of a class of persons who acquired our common stock in or traceable to the Company’s secondary public offering commenced on or about March 1, 2019. The complaint alleged that the defendants violated the federal securities laws by, among other things, making misrepresentations about the Company’s commercial relationships and failing to disclose certain material adverse facts, trends or uncertainties or significant risks that made the secondary public offering speculative and risky. The complaint sought rescission or rescissory damages and compensatory damages. In August 2022, the Company received preliminary approval by the Court for settlement of this case. Based on facts and circumstances known to the Company, which include confirmation of the claim by the Company’s insurance broker and that it is a remote probability that the estimated recovery under the claim will change, in the second quarter of 2022, the Company recorded an insurance recovery of $ 9,240 to prepaid and other current assets, with a corresponding liability recorded to accrued expenses in the second quarter 2022. On September 15, 2022, all fees associated with the legal settlement were deposited in the special escrow with the Court, and the entire insurance recovery and accrued expense were relieved. Final approval from the Court is expected in the fourth quarter of 2022. Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable. All of the Company’s cash, cash equivalents and restricted cash are held at financial institutions that management believes to be of high credit quality. The bank deposits of the Company exceed federally insured limits and are generally uninsured and uncollateralized. The Company has not experienced any losses on cash, cash equivalents and restricted cash to date. To manage accounts receivable risk, the Company evaluates the creditworthiness of its customers and maintains an allowance for credit losses. Accounts receivable are unsecured and derived from revenue earned from customers located in the United States. No customer exceeded 10 % of accounts receivable as of September 30, 2022 and December 31, 2021. No customer exceeded 10 % of total revenue in any of the three- and nine-month periods ended September 30, 2022 and 2021. Allowance for Credit Losses The Company uses a current expected credit loss model. Accounts receivable and allowance for credit losses are discussed in Note 7. Capitalized Software Development Costs The Company capitalizes certain costs related to its software developed or obtained for internal use. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Internal and external costs incurred during the application development stage, including upgrades and enhancements representing modifications that will result in significant additional functionality, are capitalized. Software maintenance and training costs are expensed as incurred. Capitalized costs are recorded as part of property and equipment and are amortized on a straight-line basis to cost of revenue over the software’s estimated useful life, which is three years . The Company evaluates these assets for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. The following tables present information about capitalized software development costs: Three Months Ended September 30, Nine Months Ended September 30, Capitalized software development costs 2022 2021 2022 2021 Capitalized $ 2,129 $ 1,886 $ 5,614 $ 5,625 Amortized $ 2,461 $ 2,268 $ 7,280 $ 6,589 Capitalized software development costs As of As of Net book value $ 14,626 $ 16,292 Leases The Company periodically enters into finance leases for property and equipment. The leasing arrangements for the Company’s office space at its headquarters campus are classified as finance leases. The Company also leases office space under operating leases. The Company determines if an arrangement is a lease at inception. Right of use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term. Lease liabilities represent an obligation to make lease payments arising from the lease. Leases with a term of 12 months or less are not included in the recognized ROU assets and lease liabilities for all classes of assets. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Because the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on information available at commencement date to determine the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives, or initial direct costs. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components (e.g., common area maintenance and equipment maintenance) that are accounted for as a single lease component. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as maintenance costs based on future obligations, are not included in the ROU assets or liabilities. These are expensed as incurred and recorded as variable lease expense. Comprehensive Loss The Company’s net loss equals comprehensive loss for all periods presented. Recently Adopted Accounting Standards Convertible Debt On January 1, 2022, the Company adopted ASU No. 2020-06, “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)”. The update simplifies the accounting for convertible debt instruments and convertible preferred stock by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. This ASU also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. The Company adopted this update using the modified retrospective transition method at the beginning of the period of adoption. Accordingly, the Company did not adjust prior period financial statements, and recognized a cumulative-effect adjustment to the opening balance of accumulated deficit in 2022 in the amount of $ 40,669 . The adoption of this standard had a significant impact on the Company’s consolidated financial statements as follows: • Removal of the equity component, net of allocated issuance costs, of the convertible senior notes of $ 52,973 recorded to additional paid-in capital resulting in an increase to the carrying amount of the liability and, cumulatively reduced non-cash interest expense ($ 40,669 of which was recorded to the opening balance of accumulated deficit); • Elimination of the $ 12,304 in unamortized discount recorded to the convertible senior notes; and • Significant reduction in prospective non-cash interest expense related to the elimination of the unamortized discount. The adoption of this standard did not impact the manner in which the Company has or will reflect the convertible senior notes in diluted earning per share.

Business Combination

Business Combination	9 Months Ended
	Sep. 30, 2022
Business Combinations [Abstract]
Business Combination	3. Business Combination On November 19, 2021, the Company purchased 100 % of the outstanding stock of Tango Health, Inc. (“Tango Health”), for total consideration of $ 28,471 . This acquisition added technology to strengthen the Company’s platform, expand its customer reach, and enhance the value the Company delivers to its Patient Protection and Affordable Care Act (“ACA”) compliance customers. As the valuation of certain assets and liabilities for purposes of purchase price allocations are preliminary in nature, they are subject to adjustment as additional information is obtained about the facts and circumstances regarding these assets and liabilities that existed at the acquisition date. Any adjustments to our estimates of acquisition accounting will be made in the periods in which the adjustments are determined, and the cumulative effect of such adjustments will be calculated as if the adjustments had been completed as of the acquisition date. The preliminary acquisition accounting will be finalized within one year from the date of acquisition. The Company believes the information gathered to date provides a reasonable basis for estimating the preliminary fair and recorded values of assets acquired and liabilities assumed. The following table summarizes the fair value of the consideration paid and the amounts of the assets acquired and liabilities assumed recognized at the acquisition date: Consideration Transferred Cash consideration transferred $ 31,628 Contingently returnable consideration ( 879 ) Consideration payable 500 Contingent consideration 675 Fair value of total purchase price consideration 31,924 Cash acquired ( 3,453 ) Fair value of total purchase price consideration, net of cash acquired $ 28,471 Recognized Amounts of Identifiable Assets Acquired and Liabilities Assumed Accounts receivable, net $ 2,866 Contract, prepaid and other current assets 453 Intangible assets 13,250 Accounts payable and accrued expenses ( 435 ) Deferred revenue, current portion ( 5,849 ) Deferred tax liability ( 3,194 ) Total identifiable net assets 7,091 Goodwill 21,380 Total identifiable net assets and goodwill $ 28,471 The goodwill of $ 21,380 arising from the acquisition relates to the growth of the business through future adaptations of the technology and the growth of the business through new customers. The goodwill recognized from this stock acquisition is not deductible for income tax purposes. The identifiable intangible assets acquired have a weighted average amortization period of 6.9 years and include developed technology, customer relationships, and trade name. The Company did no t acquire any contingent liabilities as part of the transaction. During the first quarter of 2022, the Company transferred the previously recorded consideration payable of $ 500 . In April 2022, the Company transferred approximately $ 675 in previously recorded contingent consideration related to the attainment of certain sales criteria by January 31, 2022. Additionally, consideration transferred to complete the acquisition includes contingently returnable consideration of $ 1,598 which includes a fair value adjustment of $ 719 recorded during the second quarter 2022 that is measured at fair value and classified within Level 3 of the fair value hierarchy, as presented in Note 5. The Company uses a probability weighted value analysis as the valuation technique to estimate future cash flow and subsequently converted those cash flows to a single present value amount. The significant unobservable input used in estimating the fair value of the contingently returnable consideration was a renewal of a certain customer contract that was finalized as of June 30, 2022. As of September 30, 2022, all of the contingently returnable consideration had been settled. Contract assets and deferred revenue balances were recorded at the book amounts acquired as the contract terms and performance obligations were consistent with the Company's application of the provisions of ASC Topic 606, Revenue from Contracts with Customers. All other assets acquired and liabilities were recorded at fair and recorded values. Revenue recognized by the Company related to the operations of and identifiable expenses associated with the acquired business were immaterial for the three- and nine-month periods ended September 30, 2022. Supplemental pro forma revenue and earnings information are not presented because the Company determined they were immaterial to the consolidated financial statements. The Company estimates that the difference between pro forma information compared to reported results would not be significant.

Net Loss Per Common Share

Net Loss Per Common Share	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Net Loss Per Common Share	4. Net Loss Per Common Share Diluted loss per common share is the same as basic loss per common share for all periods presented because the effects of potentially dilutive items were anti-dilutive given the Company’s net loss. The following common share equivalent securities have been excluded from the calculation of weighted average common shares outstanding because the effect is anti-dilutive for the periods presented: Three Months Ended Nine Months Ended Anti-Dilutive Common Share Equivalents 2022 2021 2022 2021 Restricted stock units 4,432,216 3,642,298 4,432,216 3,642,298 Stock options 88,000 97,553 88,000 97,553 Convertible senior notes 129,546 2,277,017 129,546 2,277,017 Conversion of preferred stock 5,333,334 5,333,334 5,333,334 5,333,334 Employee Stock Purchase Plan 6,516 4,051 6,516 4,051 Total anti-dilutive common share equivalents 9,989,612 11,354,253 9,989,612 11,354,253 Basic and diluted net loss per common share is calculated as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Numerator: Net loss $ ( 6,986 ) $ ( 18,054 ) $ ( 21,427 ) $ ( 35,171 ) Preferred dividends ( 1,600 ) ( 1,600 ) ( 4,800 ) ( 4,800 ) Net loss attributable to common stockholders $ ( 8,586 ) $ ( 19,654 ) $ ( 26,227 ) $ ( 39,971 ) Denominator: Weighted-average common shares outstanding, basic and diluted 34,279,464 33,354,624 33,937,778 32,978,394 Net loss per common share, basic and diluted $ ( 0.25 ) $ ( 0.59 ) $ ( 0.77 ) $ ( 1.21 )

Fair Value Measurement

Fair Value Measurement	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurement	5. Fair Value Measurement The carrying amounts of certain of the Company’s financial instruments, including cash and cash equivalents, net accounts receivable, accounts payable and other accrued liabilities, and accrued compensation and benefits, approximate fair value due to their short-term nature. The carrying value of the Company’s financing obligations approximates fair value, considering the borrowing rates currently available to the Company with similar terms and credit risks. The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs when determining fair value. The three tiers are defined as follows: Level 1. Quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2. Other inputs that are directly or indirectly observable in the marketplace. Level 3. Unobservable inputs for which there is little or no market data, which require the Company to develop its own assumptions. Assets and Liabilities Measured at Fair Value on a Recurring Basis The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level to classify them for each reporting period. This determination requires significant judgments to be made. The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above categories: September 30, 2022 Description Level 1 Level 2 Level 3 Total Assets: Money market mutual funds (1) $ 51,072 $ - $ - $ 51,072 Contingently returnable consideration (2) - - - - Total assets $ 51,072 $ - $ - $ 51,072 December 31, 2021 Description Level 1 Level 2 Level 3 Total Assets: Money market mutual funds (1) $ 24,150 $ - $ - $ 24,150 Available-for-sale securities - 37,049 - 37,049 Contingently returnable consideration (2) - - 879 879 Total assets $ 24,150 $ 37,049 $ 879 $ 62,078 Liabilities: Contingent consideration (2) $ - $ - $ 675 $ 675 Total liabilities $ - $ - $ 675 $ 675 (1) Money market mutual funds are classified as cash equivalents in the Company’s consolidated balance sheets, as short-term, highly liquid investments readily convertible to known amounts of cash, with remaining maturities of three months or less at the time of purchase. The Company’s cash equivalent money market funds have carrying values that approximate fair value. (2) During the year ended December 31, 2021, the Company recorded contingently returnable consideration and contingent consideration as a result of its acquisition of Tango Health. See discussion of valuation techniques and significant assumptions used in determining the fair value of these items in Note 3. Assets Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3) The following table presents information about the Company’s assets that are measured at fair value on a recurring basis using the above categories: 2022 Balance of contingently returnable consideration at January 1 $ 879 Change in fair value 719 Cash consideration transferred ( 1,598 ) Balance of contingently returnable consideration at September 30 $ -

Marketable Securities

Marketable Securities	9 Months Ended
	Sep. 30, 2022
Marketable Securities [Abstract]
Marketable Securities	6. Marketable Securities Marketable securities consist of corporate bonds, commercial paper and U.S. Treasury and agency bonds. There were no marketable securities as of September 30, 2022 . All marketable securities had contractual maturities of less than one year as of December 31, 2021. The following table presents information about the Company’s marketable securities by major security type: As of December 31, 2021 Sector Amortized cost Allowance for credit losses Net carrying amount Gross unrealized gains Gross unrealized losses Fair value Financial 37,049 - 37,049 - - 37,049 Total $ 37,049 $ - $ 37,049 $ - $ - $ 37,049 The Company invests in highly rated securities with maturities of two years or less at the time of purchase. Given the credit quality of the financial assets and the historical loss experience associated with their respective credit ratings as well as the duration of these financial assets and the short time horizon over which to consider expectations of future economic conditions, the Company has assessed that non-collection of the cost basis of these financial assets is remote.

Accounts receivable, Net

Accounts receivable, Net	9 Months Ended
	Sep. 30, 2022
Accounts Receivable Net [Abstract]
Accounts Receivable, Net	7. Accounts Receivable, net Accounts receivable, net include: As of As of Accounts receivable $ 29,578 $ 18,970 Less: Allowance for credit losses ( 115 ) ( 167 ) Less: Allowance for returns ( 1,865 ) ( 2,312 ) Total accounts receivable, net $ 27,598 $ 16,491 Accounts receivable are stated at their amortized cost adjusted for any write-offs and allowances for returns. The Company estimates expected credit losses related to accounts receivable balances based on a review of available and relevant information including current economic conditions, projected economic conditions, historical loss experience, account aging, and other factors that could affect collectability. Expected credit losses are determined individually or collectively depending on whether the accounts receivable balances share similar risk characteristics. The allowance for credit losses is the best estimate of the amount of expected credit losses related to existing accounts receivable. The Company does not have any off-balance sheet credit exposure related to its customers. Nine Months Ended September 30, Allowance for credit losses 2022 2021 Beginning of period $ 167 $ 200 Provision for credit losses 20 18 Write-offs and recoveries ( 72 ) ( 26 ) End of period $ 115 $ 192 The allowances for returns are accounted for as reductions of revenue and are estimated based on the Company’s periodic assessment of historical experience and trends. The Company considers factors such as historical reasons for adjustments, service and delivery issues or delays, and past due customer billings.

Convertible Senior Notes

Convertible Senior Notes	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Convertible Senior Notes	8. Convertible Senior Notes In December 2018, the Company issued $ 240,000 aggregate principal amount of 1.25 % convertible senior notes (“Notes”) due December 15, 2023 , unless earlier repurchased by the Company or converted by the holder pursuant to their terms. Interest is payable semiannually in arrears on June 15 and December 15 of each year, commencing on June 15, 2019. The Notes are governed by an Indenture between the Company, as issuer, and U.S. Bank, National Association, as trustee. The Notes are unsecured and rank: senior in right of payment to the Company’s future indebtedness that is expressly subordinated in right of payment to the Notes; equal in right of payment to the Company’s unsecured indebtedness that is not subordinated; effectively junior in right of payment to any of the Company’s senior, secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities incurred by the Company’s subsidiaries. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of common stock, at the Company’s election. At issuance, the Notes had an initial conversion rate of 18.8076 shares of common stock per $1 principal amount of Notes, which represented an initial effective conversion price of approximately $ 53.17 per share of common stock and 4,513,824 shares issuable upon conversion. Throughout the term of the Notes, the conversion rate may be adjusted upon the occurrence of certain events. Holders of the Notes will not receive any cash payment representing accrued and unpaid interest, if any, upon conversion of a Note, except in limited circumstances. Accrued but unpaid interest will be deemed to be paid by cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock paid or delivered, as the case may be, to the holder upon conversion of Notes. Prior to the close of business on September 14, 2023, the Notes will be convertible at the option of holders during certain periods, only upon satisfaction of certain conditions set forth below. On or after September 15, 2023, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert all or any portion of their Notes at the conversion price at any time regardless of whether the conditions set forth below have been met. Holders may convert all or a portion of their Notes prior to the close of business on September 14, 2023, in multiples of $ 1 principal amount, only under the following circumstances: • during any calendar quarter commencing after the calendar quarter ending on March 31, 2019 (and only during such calendar quarter), if the last reported sales price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130 % of the conversion price on each applicable trading day; • during the five-business day period after any five consecutive trading day period, or the Notes measurement period, in which the “trading price” (as defined in the Indenture) per $ 1 principal amount of Notes for each trading day of the Notes measurement period was less than 98 % of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; • if the Company calls any or all of the Notes for redemption, at any time prior to the close of business on September 14, 2023; or • upon the occurrence of specified corporate events. As of September 30, 2022, the Notes were not convertible. Based on market data available for publicly traded, senior, unsecured corporate bonds issued by companies in the same industry and with similar maturity, the Company estimated the implied market interest rate of its Notes to be approximately 7.30 %, assuming no conversion option. Assumptions used in the estimate represent what market participants would use in pricing the liability component of the Notes, including market interest rates, credit standing, and yield curves, all of which are defined as Level 2 observable inputs. The estimated implied interest rate was applied to the Notes, which resulted in a fair value of the liability component of $ 181,500 upon issuance, calculated as the present value of future contractual payments based on the $ 240,000 aggregate principal amount. The excess of the principal amount of the liability component over its carrying amount, or the debt discount, is amortized to interest expense over the term of the Notes. The $ 58,500 difference between the gross proceeds received from issuance of the Notes of $ 240,000 and the estimated fair value of the liability component represented the equity component of the Notes and was recorded in additional paid-in capital. The equity component was not remeasured as long as it continued to meet the conditions for equity classification. As discussed in Note 2, the Company adopted ASU 2020-06 under the modified retrospective approach effective January 1, 2022. As a result of adoption, the equity component of the debt discount was eliminated. In accounting for the transaction costs related to the issuance of the Notes, the Company allocated the total amount incurred to the liability and equity components in proportion to the allocation of proceeds. Transaction costs attributable to the liability component, totaling $ 4,808 , were amortized to expense over the term of the Notes, and transaction costs attributable to the equity component, totaling $ 1,550 , were included with the equity component in shareholders’ deficit. As discussed in Note 2, the Company adopted ASU 2020-06 under the modified retrospective approach effective January 1, 2022. As a result of adoption, the remaining transaction costs, as of December 31, 2021, previously classified as equity, were reclassified to the Note liability. In August 2022, the Company repurchased Notes with an aggregate principal amount of $ 114,181 and carrying value of $ 113,557 , including accrued interest, using funds from its new delayed-draw term loan facility described in Note 9. The Company paid $ 111,627 in cash, including broker fees, resulting in a gain on the extinguishment of the liability in the amount of $ 1,930 , including $ 571 of broker fees, that is presented separately in other income (expense) in the unaudited consolidated statements of operations and comprehensive loss. In September 2021, the Company repurchased Notes with an aggregate principal amount of $ 100,181 and carrying value of $ 87,592 , including accrued interest. The Company paid $ 98,678 in cash of which $ 95,113 , including broker fees, was allocated to the liability component of the Notes and $ 3,566 was allocated to the equity component and recorded as an adjustment to additional paid-in capital. The Company recognized a loss on the extinguishment of the liability in the amount of $ 7,520 , including $ 501 of broker fees, that is presented separately in other income (expense) in the unaudited consolidated statements of operations and comprehensive loss. The Notes consist of the following: As of September 30, 2022 December 31, 2021 Liability component: Principal $ 6,888 $ 121,069 Less: Debt discount, net of amortization (1) ( 52 ) ( 13,788 ) Net carrying amount $ 6,836 $ 107,281 Equity component (prior to adoption of ASU 2020-06) (2) - 52,973 Remaining discount amortization period (in years) 1.21 (1) As discussed in Note 2, the Company adopted ASU 2020-06 under the modified retrospective approach effective January 1, 2022. The result was a significant reduction in the recorded debt discount and the related amortization expense. (2) Recorded in the consolidated balance sheet within additional paid-in capital, net of $ 1,550 transaction costs in equity. The remaining balance of these transaction costs was $ 432 as of December 31, 2021. The following table sets forth total interest expense recognized related to the Notes: Three Months Ended September 30, Nine Months Ended September 30, Interest expense 2022 2021 2022 2021 1.25% coupon $ 259 $ 656 $ 1,016 $ 2,039 Amortization of debt discount and transaction costs (1) 130 2,811 507 8,591 Total interest expense $ 389 $ 3,467 $ 1,523 $ 10,630 _________________ (1) As discussed in Note 2, the Company adopted ASU 2020-06 under the modified retrospective approach effective January 1, 2022. The result was a significant reduction in the recorded debt discount and the related amortization expense. As of September 30, 2022, the fair value of the Notes, which was determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, quoted price of the Notes in an over-the-counter market (Level 2), and carrying value of debt instruments (carrying value excludes the equity component of the Company’s Notes classified in equity prior to the adoption of ASU 2020-06 on January 1, 2022 as discussed in Note 2) were as follows: September 30, 2022 December 31, 2021 Fair Value Carrying Value (1) Fair Value Carrying Value Convertible senior notes $ 6,199 $ 6,836 $ 113,805 $ 107,281 (1) As discussed in Note 2, the Company adopted ASU 2020-06 under the modified retrospective approach effective January 1, 2022 resulting in a $ 12,304 net increase in the carrying value of the Notes. In connection with the issuance of the Notes, the Company entered into capped call transactions with certain counterparties affiliated with the initial purchasers and others. The capped call transactions are expected to reduce potential dilution of earnings per share upon conversion of the Notes. Under the capped call transactions, the Company purchased capped call options that in the aggregate relate to the total number of shares of the Company’s common stock underlying the Notes, with an initial strike price of approximately $ 53.17 per share, which corresponds to the initial conversion price of the Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Notes, and have a cap price of approximately $ 89.98 . The cost of the purchased capped calls of $ 33,024 was recorded to stockholders’ deficit and will not be re-measured provided it continues to meet the conditions for equity classification. In connection with the repurchases of the Notes described above, the Company terminated a portion of the capped call transactions. This resulted an immaterial amount of cash payments to the Company during the three months ended September 30, 2022, which were recorded in additional paid-in capital. During the three months ended September 30, 2021, the Company received $ 98 of cash payments in connection with the termination of capped calls, which was recorded in additional paid-in capital. Based on the closing price of our common stock of $ 6.35 on September 30, 2022 , the last trading day of the quarter, the if-converted value of the Notes was less than their respective principal amounts.

Long-term Debt

Long-term Debt	9 Months Ended
	Sep. 30, 2022
Extinguishment of Debt [Line Items]
Long-term Debt	10. Revolving Line of Credit The Company entered into a credit facility with Silicon Valley Bank providing for a revolving line of credit agreement on March 3, 2020 ("SVB Revolver"). The three-year facility had a borrowing limit of $ 50,000 , with the ability for the Company to increase it up to $ 100,000 . In connection with the Company's new Credit Agreement, as discussed in Note 9, the SVB Revolver was terminated in the third quarter of 2022 and all related liens were released. No amounts were borrowed or repaid under the SVB Revolver during each of the nine months ended September 30, 2022 and 2021.
Long-term Debt
Extinguishment of Debt [Line Items]
Long-term Debt	9. Long-term Debt The Company entered into a Credit Agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A., as administrative agent, joint lead arranger and sole bookrunner and Wells Fargo Securities, LLC and Regions Bank as joint lead arrangers on August 17, 2022 (the "Effective Date"). This Credit Agreement replaced the Company's previous credit facility with Silicon Valley Bank as discussed in Note 10. The four-year Credit Agreement includes (i) a $ 15,000 revolving credit facility (the “Revolving Credit Facility”), which includes a $ 10,000 sublimit for the issuance of standby letters of credit and a $ 10,000 sublimit for swingline loans, and (ii) a $ 125,000 delayed-draw term loan facility (the “Term Facility,” which, together with the Revolving Credit Facility, comprises the Credit Agreement). Principal payments on the Revolving Credit Facility are due on the maturity date. Principal payments on the Term Facility are due quarterly commencing on the last day of the first full quarter after the initial borrowing. Each such payment of the Term Facility is an aggregate principal amount equal to a percentage of 1.25 % commencing December 31, 2022 through June 30, 2024 and increasing to 1.875 % for quarters ending September 30, 2024 through maturity multiplied by the aggregate principal amount of the Term Facility funded. To the extent not previously repaid, all unpaid Term Facility loans must be paid on the maturity date. The Company may prepay the Credit Agreement in whole or in part at any time without premium or penalty. Under the Term Facility, borrowings are available to be drawn prior to the 18th month anniversary of the Effective Date in up to three separate drawings of not less than $ 5,000 (provided that only one drawing can occur after the first anniversary of the Effective Date). The Credit Agreement includes provisions permitting the Borrower to request increases in the amount of revolving and term loan commitments made available to the Company, in amounts of not less than $ 5,000 and in an aggregate amount not to exceed $ 50,000 . The Company's obligations under the Credit Agreement are secured by a first priority lien (subject to certain permitted liens) in substantially all of the respective personal property assets of the Company and its subsidiaries. Loans under the Revolving Credit Facility and Term Facility bear interest at a rate per annum determined by the Company's consolidated leverage ratio with a margin on Secured Overnight Financing Rate ("SOFR") priced loans ranging from 2.00 - 3.25 % and a margin on Alternative Base Rate ("ABR") priced loans ranging from 1.00 % - 2.25 %. The Company will pay a commitment fee on the daily unused revolving commitments and a fee on the daily unused delayed draw term loan commitments at a rate based on the Company’s leverage ratio and ranging from 0.20 % to 0.40 % per year. The Credit Agreement includes customary affirmative and negative covenants, including financial covenants requiring the Company to maintain a maximum consolidated total net leverage ratio and minimum debt service coverage ratio, and certain limitations on the incurrence of additional indebtedness and liens, as well as usual and customary events of default for credit facilities of this nature. In August 2022, the Company borrowed $ 112,000 pursuant to the Term Facility and used the proceeds to repurchase the majority of its outstanding convertible senior notes as discussed in Note 8. No amounts were borrowed or repaid under the Revolving Credit Facility during the three months ended September 30, 2022 . There were no amounts outstanding under the Revolving Credit Facility and $ 112,000 outstanding under the Term Facility as of September 30, 2022. The amounts available to borrow under the Revolving Credit Facility and the Term Facility were $ 15,000 and $ 13,000 , respectively. The interest rate was 5.56 % as of September 30, 2022. As of September 30, 2022, the aggregate amount of the Term Facility principal payments was as follows: Aggregate Principal Payment Years Ending December 31, 2022 - remaining $ 1,400 2023 5,600 2024 7,000 2025 8,400 2026 89,600 Total required principal payments $ 112,000

Revolving Line of Credit

Revolving Line of Credit	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Revolving Line of Credit	10. Revolving Line of Credit The Company entered into a credit facility with Silicon Valley Bank providing for a revolving line of credit agreement on March 3, 2020 ("SVB Revolver"). The three-year facility had a borrowing limit of $ 50,000 , with the ability for the Company to increase it up to $ 100,000 . In connection with the Company's new Credit Agreement, as discussed in Note 9, the SVB Revolver was terminated in the third quarter of 2022 and all related liens were released. No amounts were borrowed or repaid under the SVB Revolver during each of the nine months ended September 30, 2022 and 2021.

Commitments

Commitments	9 Months Ended
	Sep. 30, 2022
Commitments And Contingencies Disclosure [Abstract]
Commitments	11. Commitments Supplemental cash flow information related to the Company’s operating and finance leases was as follows: Nine Months Ended September 30, Cash Paid for Amounts Included in the Measurement of Lease Liabilities 2022 2021 Financing cash flows from finance leases $ 5,686 $ 3,902 Operating cash flows from finance leases $ 5,151 $ 2,598 Operating cash flows from operating leases $ 359 $ 362 ROU Assets Obtained in Exchange for New Lease Obligations Finance lease liabilities $ - $ 478 As of September 30, 2022, the Company had no additional significant operating or finance leases that had not yet commenced. In May 2022, the Company entered into a non-cancellable sublease agreement for a portion of its headquarters campus. The sublease term expires May 31, 2028 and may be renewed at the option of the sublessee through November 30, 2031. Because rental market conditions have declined since the Company entered into its lease, payments to the Company under the sublease are less than its current obligation for the asset. Accordingly, the Company recorded an impairment loss of the financing lease ROU asset of $ 1,769 based on the excess of the carrying amount over the calculated fair value of the sublease. This impairment expense was included in operating expenses in the Company’s consolidated statements of operations and comprehensive loss for the nine-month period ended September 30, 2022. In April 2021, the Company entered into a non-cancellable sublease agreement for a portion of its headquarters campus. The sublease term expires May 31, 2028 and may be renewed at the option of the sublessee through November 30, 2031. Because market conditions and value have declined since the Company entered into its lease, payments to the Company under the sublease are less than its current obligation for the asset. Accordingly, the Company recorded an impairment loss of the financing lease ROU asset of $ 4,003 based on the excess of the carrying amount over the calculated fair value of the sublease. This impairment expense was included in operating expenses in the Company’s consolidated statements of operations and comprehensive loss for the nine- month period ended September 30, 2021.

Redeemable Preferred Stock

Redeemable Preferred Stock	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Redeemable Preferred Stock	12. Redeemable Preferred Stock On June 4, 2020, the Company issued and sold 1,777,778 shares of its newly created series of preferred stock, par value of $ 0.001 per share, designated as “Series A Convertible Preferred Stock” (the “Preferred Stock”) to BuildGroup LLC (the “Buyer”) at a purchase price of $ 45 per share, resulting in total gross proceeds for the Company of approximately $ 80,000 . A member of the Company’s Board of Directors is the Chief Executive Officer of the Buyer. The Buyer also has a second representative on the Board. The Preferred Stock ranks senior to the Company’s common stock with respect to dividends and distributions on liquidation, winding-up and dissolution. Each share of the Preferred Stock has an initial stated value of $ 45 per share. Holders of shares of the Preferred Stock are entitled to a dividend equal to 8.00 % per annum (the “Regular Dividends”), payable quarterly, beginning on June 30, 2020. The Regular Dividends are payable in cash or in kind, at the Company’s option. In the event a Regular Dividend is paid in kind, the stated value of each share of the Preferred Stock will be increased by an amount equal to the accrued Regular Dividend not paid in cash. As of September 30, 2022, the Company had paid all dividends on the Preferred Stock in cash. Holders of the Preferred Stock are also entitled to participate in and receive any dividends declared or paid on the common stock on an as-converted basis, and no dividends may be paid to holders of the common stock unless full participating dividends are concurrently paid to the holders of the Preferred Stock. Each holder of the Preferred Stock has the right, at its option, to convert its shares of the Preferred Stock, in whole or in part, into fully paid and non-assessable shares of the common stock, at any time and from time to time. The number of shares of the common stock into which a share of the Preferred Stock will convert at any time is equal to the quotient obtained by dividing its stated value then in effect plus any accumulated and unpaid Regular Dividends by its conversion price of $ 15.00 . The conversion price is subject to customary anti-dilution adjustments, including adjustments in the event of any stock split, stock dividend, recapitalization or similar events. At closing, before payment of any dividends in kind, the 1,777,778 shares of the Preferred Stock were convertible into 5,333,334 shares of common stock. The Company may, at its option, redeem the outstanding shares of the Preferred Stock following the fourth anniversary of its issuance. Redemption by the Company is subject to certain liquidity conditions as well as conditions connected with the trading price of its common stock. Upon redemption by the Company, the Company will pay the holder of the Preferred Stock 105 % of the initial stated value of such share plus any increase in the stated value from the initial stated value plus accumulated and unpaid Regular Dividends. If the Company undergoes a change of control as defined in the purchase agreement, the Company must redeem all of the then-outstanding shares of the Preferred Stock for cash consideration equal to the greater of the amount due for redemption as described above and the amount such holder of shares of the Preferred Stock would have received in respect of the number of shares of the Common Stock that would be issuable upon conversion of such share of the Series A Preferred Stock. Unless and until approval of the Company’s stockholders is obtained as contemplated by the NASDAQ listing rules, no holder of the Preferred Stock may convert shares of the Preferred Stock into shares of common stock if and to the extent that such conversion would result in the holder beneficially owning in excess of 19.9 % of the then-outstanding shares of the common stock. As long as not less than 60 % of the shares of the Preferred Stock originally issued remain outstanding, the holders of a majority of the then-outstanding shares of the Preferred Stock, voting together as a single class, have the right at any election of directors to elect two directors if the Board consists of nine or fewer directors or three directors if the Board consists of 10 directors. At any time, such elected director(s) may be removed with or without cause only by the affirmative vote or written consent of a majority of the holders of the Preferred Stock entitled to elect such director. Holders of the Preferred Stock generally are entitled to vote with the holders of the shares of the common stock on all matters submitted for a vote of holders of shares of the common stock (voting together with the holders of shares of the common stock as one class) on an as-converted basis, subject to a limitation of ownership of 19.9 % of common stock. Additionally, certain matters require the approval of the holders of a majority of the outstanding shares of the Preferred Stock, voting as a separate class. The Buyer is subject to limitations while it holds at least 10 % of the Preferred Stock originally purchased. Furthermore, until the earliest of May 30, 2024 and receipt of a notice of redemption, the Buyer cannot sell, transfer or otherwise dispose of the shares of the Preferred Stock or the underlying shares of the common stock, subject to limited exceptions that include exceptions in the case of transfers to certain permitted transferees. For so long as the Buyer and its affiliates collectively hold at least 60 % of the shares of the Preferred Stock originally purchased by it or the common stock issuable upon conversion thereof, the Company will pay the Buyer a fee of $ 400 for the first year following closing and $ 200 per year thereafter. These management and oversight fees are expensed over the period incurred. In the period of issuance, the Company incurred $ 807 in issuance costs related to the sale of the Preferred Stock, including $ 150 of reimbursement to the Buyer for reasonable fees and out-of-pocket expenses incurred by the Buyer in connection with the transaction. The issuance costs were netted against the proceeds from this transaction.

Stock-based Compensation

Stock-based Compensation	9 Months Ended
	Sep. 30, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-based Compensation	13. Stock-based Compensation Restricted Stock Units During the nine months ended September 30, 2022, the Company granted 2,028,433 restricted stock units, or RSUs, to employees and officers with an aggregate grant date fair value of $ 22,712 . These RSUs vest in equal annual installments over various periods generally ranging from three years to up to four years from the grant date, subject to continued service to the Company. The Company amortizes the grant date fair value of the stock subject to the RSUs on a straight-line basis over the period of vesting. The weighted-average vesting period for these RSUs is 3.85 years from the date of grant. The Company granted 931,292 performance RSUs with an aggregate grant date fair value of $ 11,227 during the nine months ended September 30, 2022. The aggregate grant date fair value of the performance RSUs assuming target achievement was $ 8,436 . The number of performance RSUs that will vest will be determined upon the achievement of certain financial targets for 2022 , and vesting will then occur in equal annual installments generally over one year or four years from the grant date. The actual number of shares issued upon vesting could range between 0 % and 100 % of the number of awards granted. The grant date fair value of the stock subject to the performance RSUs is amortized to expense on an accelerated basis over the period of vesting. The weighted-average vesting period for these performance RSUs is approximately 3.26 years from the date of grant.

Stockholders' Deficit

Stockholders' Deficit	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders' Deficit	14. Stockholders’ Deficit Common Stock The holders of common stock are entitled to one vote for each share. The voting, dividend and liquidation rights of the holders of common stock are subject to and qualified by the rights, powers and preferences of the holders of preferred stock. At September 30, 2022, the Company had reserved a total of 13,335,298 of its authorized 95,000,000 shares of common stock for future issuance as follows: Outstanding stock options 88,000 Restricted stock units 4,432,216 Available for future issuance under stock award plans 3,410,734 Available for future issuance under ESPP 71,014 Issuable upon conversion of Series A Preferred Stock 5,333,334 Total common shares reserved for future issuance 13,335,298

Revenue

Revenue	9 Months Ended
	Sep. 30, 2022
Revenue From Contract With Customer [Abstract]
Revenue	15. Revenue Disaggregation of Revenue The following table provide information about disaggregation of revenue by service line: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Service line: Subscription $ 41,248 $ 44,790 $ 126,320 $ 134,716 Platform 5,643 6,157 18,786 19,801 Total software services $ 46,891 $ 50,947 $ 145,106 $ 154,517 Professional services 9,299 11,079 28,896 33,476 Total $ 56,190 $ 62,026 $ 174,002 $ 187,993 Contract Balances The following table provides information about contract assets and contract liabilities from contracts with customers: Balance at Beginning of Period Balance at End of Period Nine Months Ended September 30, 2022 Contract assets $ 18,051 $ 9,357 Contract liabilities Deferred revenue $ 30,133 $ 32,807 Nine Months Ended September 30, 2021 Contract assets $ 15,105 $ 7,076 Contract liabilities Deferred revenue $ 32,204 $ 28,764 The Company recognizes payments from customers based on contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company’s contractual right to consideration for completed performance objectives not yet invoiced. Contract liabilities include payments received in advance of performance under the contract and are recognized as revenue when earned under the contract. The Company had no asset impairment charges related to contract assets during each of the three- and nine-month periods ended September 30, 2022 and 2021. During the three- and nine-month periods ended September 30, 2022 , there were no significant changes in the contract assets outside of standard revenue and billing activity. Revenue recognized during the three- and nine-month periods ended September 30, 2022 that was included in the deferred revenue balance at the beginning of the period was $ 12,835 and $ 26,734 , respectively. During the three- and nine-month periods ended September 30, 2022 , there were no significant adjustments to revenue arising from performance obligations satisfied or partially satisfied in previous periods. Performance Obligations As of September 30, 2022, the aggregate amount of the Company’s performance obligations that are unsatisfied or partially unsatisfied were approximately $ 221,795 , of which a majority are expected to be satisfied within the next three years . The Company excludes from its population of performance obligations contracts with original durations of one year or less, contract renewal periods that renew automatically, and amounts of variable consideration that are allocated to wholly unsatisfied distinct service that forms part of a single performance obligation and meets certain variable allocation criteria.

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	16. Income Taxes The Company’s effective tax rate for the nine months ended September 30, 2022 was less than two percent, primarily as a result of estimated taxable income for the fiscal year-to-date offset by the utilization of net operating loss carryforwards. Tax expense relates to estimated state income taxes and indefinite life intangibles. The limitation on the utilization of net operating losses in the indefinite life period is limited to 80 % of taxable income because of provisions in the Tax Cuts and Jobs Act.

Segments Information

Segments Information	9 Months Ended
	Sep. 30, 2022
Segment Reporting [Abstract]
Segments Information	17. Segments Information The Company views its operations and manages its business as one operating segment. Segment information matches the consolidated financial information for the current period and prior periods reported.

Related Parties

Related Parties	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Parties	18. Related Parties Series A Preferred Stock As described in Note 12, the Company sold 1,777,778 shares of Preferred Stock to an entity (the “Buyer”) whose Chief Executive Officer is a member of the Company’s Board of Directors. The Company paid dividends of $ 1,600 to the Buyer in each of the three-month periods ended September 30, 2022 and 2021, and $ 4,800 to the Buyer in each of the nine-month periods ended September 30, 2022 and 2021. Additionally, the Company paid management oversight fees of $ 50 and $ 150 the Buyer for the three- and nine-month periods ended September 30, 2022 , respectively, and $ 186 to the Buyer for the nine- month periods ended September 30, 2021. There were no management oversight fees due to the Buyer as of September 30, 2022 or December 31, 2021. Expenses During April 2022, the Company made a one-time reimbursement of $ 600 for agreed upon fees and expenses, including legal expenses, to an entity which is a significant stockholder and whose Investment Partner is a member of the Company’s Board of Directors.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	19. Subsequent Events Voya Merger Agreement On November 1, 2022, the Company, Voya Financial, Inc., a Delaware corporation (“Voya”), and Origami Squirrel Acquisition Corp, a Delaware corporation and a wholly owned subsidiary of Voya (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Voya Merger Agreement”). Pursuant to the terms and subject to the conditions set forth in the Voya Merger Agreement, Voya will acquire all outstanding shares of the Company for $1 0.50 per share of common stock in cash, and Merger Sub will merge with and into the Company (the “Voya Merger”), with the Company surviving the Voya Merger as a wholly owned subsidiary of Voya. Each share of our preferred stock issued and outstanding immediately prior to the effective time of the Voya Merger will be converted into the right to receive an amount of cash equal to the Convertible Preferred Liquidation Amount (as such term is defined in the Voya Merger Agreement). The Voya Merger Agreement and the Voya Merger has been unanimously approved by our Board of Directors. The Voya Merger is expected to close in the first quarter of 2023, subject to, among other things, the receipt of approval of the Company’s stockholders and customary closing conditions. Support Agreements On November 1, 2022, concurrently with the execution of the Voya Merger Agreement, Voya, Merger Sub and the Company entered into a Support Agreement (each, a “Support Agreement”) with each of BuildGroup, LLC (“BuildGroup”) and Indaba Capital Management, L.P. (“Indaba”) pursuant to which each of BuildGroup and Indaba agreed to, among other things, vote their shares of capital stock of the Company, which together represent approximately 24 % of the outstanding voting power of the Company’s capital stock, in favor of the adoption of the Voya Merger.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation These consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in the consolidation. The Company is not the primary beneficiary of, nor does it have a controlling financial interest in, any variable interest entity. Accordingly, the Company has not consolidated any variable interest entity.
Interim Unaudited Consolidated Financial Information	Interim Unaudited Consolidated Financial Information The accompanying unaudited consolidated financial statements and footnotes have been prepared in accordance with GAAP as contained in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (the “Codification” or “ASC”) for interim financial information, and with Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all adjustments of a normal recurring nature necessary for a fair presentation of the results of operations and comprehensive loss, financial position, changes in stockholders’ deficit and cash flows. The results of operations and comprehensive loss for the three- and nine-month periods ended September 30, 2022 are not necessarily indicative of the results for the full year or for any other future periods. These unaudited consolidated financial statements should be read in conjunction with the audited financial statements and related footnotes for the year ended December 31, 2021 included in the Company’s Annual Report on Form 10-K, as amended.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Such estimates include allowances for credit losses and returns, valuations of deferred income taxes, long-lived assets, capitalizable software development costs and the related amortization, contingent consideration, incremental borrowing rate used in lease accounting, the determination of the useful lives of assets, and the impairment assessment of right-of-use assets, acquired intangibles and goodwill. Additionally, as described in revenue and deferred revenue below, estimates are utilized in association with revenue recognition, in particular the estimation of variable consideration using the expected value method from insurance broker commissions reported in Platform revenue. Determination of these transactions and account balances are based on, among other things, the Company’s estimates and judgments. These estimates are based on the Company’s knowledge of current events and actions it may undertake in the future as well as on various other assumptions that it believes to be reasonable. Actual results could differ materially from these estimates.
Restructuring Cost	Restructuring Costs Restructuring costs are comprised of one-time severance charges, continuation of health benefits and outplacement services and are presented separately in operating expenses in the consolidated statements of operations and comprehensive loss. The Company recorded restructuring costs of $ 1,006 and $ 1,400 from a reduction to its workforce during January 2022 and 2021, respectively. In June 2021, the Company recorded restructuring costs of $ 2,727 from the elimination of the office of the executive chairman of the Board of Directors.
Revenue and Deferred Revenue	Revenue and Deferred Revenue The Company derives its revenue primarily from fees for subscription services and professional services sold to employers and health plans as well as platform revenue derived from the value of products sold on its platform. Revenue is recognized when control of these services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Taxes collected from customers relating to services and remitted to governmental authorities are excluded from revenue. The Company determines revenue recognition through the following steps: • Identification of each contract with a customer; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, performance obligations are satisfied. Software Services Revenue Software services revenue consists of subscription revenue and platform revenue. Subscription Revenue Subscription revenue primarily consists of monthly or annual subscription fees paid to the Company by its employer and health plan customers for access to, and usage of, cloud-based benefits software solutions for a specified contract term. Fees are generally charged based on the number of employees or subscribers with access to the solution. Subscription services revenue is generally recognized on a ratable basis over the contract term beginning on the date the subscription services are made available to the customer. The Company’s subscription service contracts are generally three years. Subscription revenue also includes fees paid for other services, such as event sponsorships and certain data services. Platform Revenue Platform revenue is generated from the value of policies or products enrolled in through the Company’s marketplace. Platform revenue from insurance carriers is generally recognized over the policy period of the enrolled products. In arrangements where the Company sells policies to employees of its customers as the broker, it earns broker commissions. Revenue from insurance broker commissions and supplier transactions is recognized at a point in time when the orders for the policies are received and transferred to the insurance carrier or supplier and is reduced by constraints for variable consideration associated with collectability, policy cancellation and termination risks. Professional Services Revenue Professional services revenue primarily consists of fees related to the implementation of software products purchased by customers. Professional services typically include discovery, configuration and deployment, integration, testing, and training. Fees from consulting services and support services are also included in professional services revenue. The Company determined that implementation services for certain of its health plan customers significantly modify or customize the software solution and, as such, do not represent a distinct performance obligation. Accordingly, revenue from such implementation services with these health plan customers are generally recognized over the contract term of the associated subscription services contract, including any extension periods representing a material right. In certain arrangements, the Company utilizes estimates of hours as a measure of progress to determine revenue. Revenue from implementation services with employer customers is generally recognized as those services are performed. Revenue from support is recognized over the service period. Contracts with Multiple Performance Obligations Certain of the Company’s contracts with customers contain multiple performance obligations. For these contracts, the individual performance obligations are accounted for separately if they are distinct. The Company allocates the transaction price to the separate performance obligations based on their relative standalone selling prices. The Company determines the standalone selling prices based on its overall pricing objectives, taking into consideration market conditions and other factors, including the value of its contracts, the subscription services sold, customer size and complexity, and the number and types of users under the contracts.
Contract Costs	Contract Costs The Company capitalizes costs to obtain contracts that are considered incremental and recoverable, such as sales commissions. Payments of sales commissions generally include multiple payments. The Company capitalizes only those payments made within an insignificant time from the contract inception, typically three months or less. Subsequent payments are expensed as incurred. The capitalized costs are amortized to sales and marketing expense over the estimated period of benefit of the asset, which is generally four to five years . The Company expenses the costs to obtain a contract when the amortization period is less than one year. Capitalized fulfillment costs are reviewed for impairment if changes to customer contracts result in termination or partial termination of services. Deferred costs related to obtaining contracts are included in deferred contract costs and other non-current assets. The Company capitalizes contract fulfillment costs directly associated with customer contracts that are not related to satisfying performance obligations. The costs are amortized to cost of revenue expense over the estimated period of benefit, which is generally five years . Deferred fulfillment costs are included in deferred contract costs and other non-current assets. The following tables present information about deferred contract costs: Balance of deferred contract costs As of As of Costs to obtain contracts $ 3,190 $ 4,418 Costs to fulfill contracts $ 1,678 $ 2,887 Three Months Ended September 30, Nine Months Ended September 30, Amortization of deferred contract costs 2022 2021 2022 2021 Costs to obtain contracts included in sales and marketing expense $ 593 $ 753 $ 1,836 $ 2,276 Costs to fulfill contracts included in cost of revenue $ 207 $ 308 $ 686 $ 998
Cost of Revenue	Cost of Revenue Cost of revenue primarily consists of employee compensation, professional services, data center co-location costs, networking expenses, depreciation expense for computer equipment directly associated with generating revenue, amortization expense for capitalized software development costs, amortization of acquired intangibles, and infrastructure maintenance costs. In addition, the Company allocates a portion of overhead, such as facilities and security costs, additional depreciation and amortization expense, and employee benefit costs to cost of revenue based on headcount.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of bank checking accounts and money market accounts. The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents
Restricted Cash	Restricted Cash Restricted cash consists of voluntary benefits premiums collected by the Company from its customer members. Restricted cash amounts are segregated in separate bank accounts and are used exclusively for the payment of the related amounts due to third-party insurance providers for benefits enrolled in by customer members. This usage restriction is contractually imposed and reflects the Company’s intention with regards to such deposits. Restricted cash was de minimis as of September 30, 2022 and there was no restricted cash as of December 31, 2021
Marketable Securities	Marketable Securities Marketable securities consist of short-term investments in corporate bonds, commercial paper, and U.S. Treasury and agency bonds. During the year ended December 31, 2021, the Company changed the classification of its marketable securities from held-to-maturity to available-for-sale based on its intent to sell the securities. The Company’s available-for-sale marketable securities are recorded at fair value which approximates cost due to the short duration of such securities. Debt securities classified as either available-for-sale or held-to-maturity are subject to the expected credit loss model prescribed under Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses of Financial Instruments”. The Company utilizes a lifetime expected credit loss measurement objective for the recognition of credit losses for debt securities at the time the financial asset is originated or acquired. The Company measures expected credit losses on its debt portfolio on a collective basis by major security type. The expected credit losses are adjusted each period for changes in expected lifetime credit losses. The Company’s credit loss calculations for debt securities are based upon historical default and recovery rates of bonds rated with the same rating as its portfolio. An adjustment factor is applied to these credit loss calculations based upon the Company’s assessment of the expected impact from current economic conditions on its investments. The Company monitors the credit quality of debt securities through the use of their respective credit rating and updates them on a quarterly basis. The allowance for credit losses is discussed in Note 7.
Insurance Recovery	Insurance Recovery The Company and several other defendants were involved with a legal proceeding regarding a complaint filed by the City of Pittsburgh Comprehensive Municipal Pension Trust Fund in the Supreme Court of the State of New York, County of New York (the “Court”). The complaint asserted claims on behalf of a class of persons who acquired our common stock in or traceable to the Company’s secondary public offering commenced on or about March 1, 2019. The complaint alleged that the defendants violated the federal securities laws by, among other things, making misrepresentations about the Company’s commercial relationships and failing to disclose certain material adverse facts, trends or uncertainties or significant risks that made the secondary public offering speculative and risky. The complaint sought rescission or rescissory damages and compensatory damages. In August 2022, the Company received preliminary approval by the Court for settlement of this case. Based on facts and circumstances known to the Company, which include confirmation of the claim by the Company’s insurance broker and that it is a remote probability that the estimated recovery under the claim will change, in the second quarter of 2022, the Company recorded an insurance recovery of $ 9,240 to prepaid and other current assets, with a corresponding liability recorded to accrued expenses in the second quarter 2022. On September 15, 2022, all fees associated with the legal settlement were deposited in the special escrow with the Court, and the entire insurance recovery and accrued expense were relieved. Final approval from the Court is expected in the fourth quarter of 2022.
Concentrations of Credit Risk	Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities and accounts receivable. All of the Company’s cash, cash equivalents and restricted cash are held at financial institutions that management believes to be of high credit quality. The bank deposits of the Company exceed federally insured limits and are generally uninsured and uncollateralized. The Company has not experienced any losses on cash, cash equivalents and restricted cash to date. To manage accounts receivable risk, the Company evaluates the creditworthiness of its customers and maintains an allowance for credit losses. Accounts receivable are unsecured and derived from revenue earned from customers located in the United States. No customer exceeded 10 % of accounts receivable as of September 30, 2022 and December 31, 2021. No customer exceeded 10 % of total revenue in any of the three- and nine-month periods ended September 30, 2022 and 2021.
Allowance for Credit Losses	Allowance for Credit Losses The Company uses a current expected credit loss model. Accounts receivable and allowance for credit losses are discussed in Note 7.
Capitalized Software Development Costs	Capitalized Software Development Costs The Company capitalizes certain costs related to its software developed or obtained for internal use. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Internal and external costs incurred during the application development stage, including upgrades and enhancements representing modifications that will result in significant additional functionality, are capitalized. Software maintenance and training costs are expensed as incurred. Capitalized costs are recorded as part of property and equipment and are amortized on a straight-line basis to cost of revenue over the software’s estimated useful life, which is three years . The Company evaluates these assets for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. The following tables present information about capitalized software development costs: Three Months Ended September 30, Nine Months Ended September 30, Capitalized software development costs 2022 2021 2022 2021 Capitalized $ 2,129 $ 1,886 $ 5,614 $ 5,625 Amortized $ 2,461 $ 2,268 $ 7,280 $ 6,589 Capitalized software development costs As of As of Net book value $ 14,626 $ 16,292
Leases	Leases The Company periodically enters into finance leases for property and equipment. The leasing arrangements for the Company’s office space at its headquarters campus are classified as finance leases. The Company also leases office space under operating leases. The Company determines if an arrangement is a lease at inception. Right of use (“ROU”) assets represent the Company’s right to use an underlying asset for the lease term. Lease liabilities represent an obligation to make lease payments arising from the lease. Leases with a term of 12 months or less are not included in the recognized ROU assets and lease liabilities for all classes of assets. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Because the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on information available at commencement date to determine the present value of lease payments. The ROU asset also consists of any prepaid lease payments, lease incentives, or initial direct costs. The lease terms used to calculate the ROU asset and related lease liability include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense while the expense for finance leases is recognized as depreciation expense and interest expense. The Company has lease agreements which require payments for lease and non-lease components (e.g., common area maintenance and equipment maintenance) that are accounted for as a single lease component. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as maintenance costs based on future obligations, are not included in the ROU assets or liabilities. These are expensed as incurred and recorded as variable lease expense.
Comprehensive Loss	Comprehensive Loss The Company’s net loss equals comprehensive loss for all periods presented.
Recently Adopted Accounting Standards	Recently Adopted Accounting Standards Convertible Debt On January 1, 2022, the Company adopted ASU No. 2020-06, “Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40)”. The update simplifies the accounting for convertible debt instruments and convertible preferred stock by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. This ASU also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. The Company adopted this update using the modified retrospective transition method at the beginning of the period of adoption. Accordingly, the Company did not adjust prior period financial statements, and recognized a cumulative-effect adjustment to the opening balance of accumulated deficit in 2022 in the amount of $ 40,669 . The adoption of this standard had a significant impact on the Company’s consolidated financial statements as follows: • Removal of the equity component, net of allocated issuance costs, of the convertible senior notes of $ 52,973 recorded to additional paid-in capital resulting in an increase to the carrying amount of the liability and, cumulatively reduced non-cash interest expense ($ 40,669 of which was recorded to the opening balance of accumulated deficit); • Elimination of the $ 12,304 in unamortized discount recorded to the convertible senior notes; and • Significant reduction in prospective non-cash interest expense related to the elimination of the unamortized discount. The adoption of this standard did not impact the manner in which the Company has or will reflect the convertible senior notes in diluted earning per share.

Summary Of Significant Accoun_3

Summary Of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule of Deferred Contract Costs	The following tables present information about deferred contract costs: Balance of deferred contract costs As of As of Costs to obtain contracts $ 3,190 $ 4,418 Costs to fulfill contracts $ 1,678 $ 2,887 Three Months Ended September 30, Nine Months Ended September 30, Amortization of deferred contract costs 2022 2021 2022 2021 Costs to obtain contracts included in sales and marketing expense $ 593 $ 753 $ 1,836 $ 2,276 Costs to fulfill contracts included in cost of revenue $ 207 $ 308 $ 686 $ 998
Schedule of Capitalized Software Development Costs	The following tables present information about capitalized software development costs: Three Months Ended September 30, Nine Months Ended September 30, Capitalized software development costs 2022 2021 2022 2021 Capitalized $ 2,129 $ 1,886 $ 5,614 $ 5,625 Amortized $ 2,461 $ 2,268 $ 7,280 $ 6,589 Capitalized software development costs As of As of Net book value $ 14,626 $ 16,292

Business Combination (Tables)

Business Combination (Tables)	9 Months Ended
	Sep. 30, 2022
Business Combinations [Abstract]
Summary of Fair Value of Consideration Paid and Amounts of Assets Acquired and Liabilities Assumed Recognized at Acquisition Date	The following table summarizes the fair value of the consideration paid and the amounts of the assets acquired and liabilities assumed recognized at the acquisition date: Consideration Transferred Cash consideration transferred $ 31,628 Contingently returnable consideration ( 879 ) Consideration payable 500 Contingent consideration 675 Fair value of total purchase price consideration 31,924 Cash acquired ( 3,453 ) Fair value of total purchase price consideration, net of cash acquired $ 28,471 Recognized Amounts of Identifiable Assets Acquired and Liabilities Assumed Accounts receivable, net $ 2,866 Contract, prepaid and other current assets 453 Intangible assets 13,250 Accounts payable and accrued expenses ( 435 ) Deferred revenue, current portion ( 5,849 ) Deferred tax liability ( 3,194 ) Total identifiable net assets 7,091 Goodwill 21,380 Total identifiable net assets and goodwill $ 28,471

Net Loss Per Common Share (Tabl

Net Loss Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Common Share Equivalent Securities Excluded from Calculation of Weighted-Average Common Shares Outstanding	The following common share equivalent securities have been excluded from the calculation of weighted average common shares outstanding because the effect is anti-dilutive for the periods presented: Three Months Ended Nine Months Ended Anti-Dilutive Common Share Equivalents 2022 2021 2022 2021 Restricted stock units 4,432,216 3,642,298 4,432,216 3,642,298 Stock options 88,000 97,553 88,000 97,553 Convertible senior notes 129,546 2,277,017 129,546 2,277,017 Conversion of preferred stock 5,333,334 5,333,334 5,333,334 5,333,334 Employee Stock Purchase Plan 6,516 4,051 6,516 4,051 Total anti-dilutive common share equivalents 9,989,612 11,354,253 9,989,612 11,354,253
Basic and Diluted Net Loss per Common Share	Basic and diluted net loss per common share is calculated as follows: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Numerator: Net loss $ ( 6,986 ) $ ( 18,054 ) $ ( 21,427 ) $ ( 35,171 ) Preferred dividends ( 1,600 ) ( 1,600 ) ( 4,800 ) ( 4,800 ) Net loss attributable to common stockholders $ ( 8,586 ) $ ( 19,654 ) $ ( 26,227 ) $ ( 39,971 ) Denominator: Weighted-average common shares outstanding, basic and diluted 34,279,464 33,354,624 33,937,778 32,978,394 Net loss per common share, basic and diluted $ ( 0.25 ) $ ( 0.59 ) $ ( 0.77 ) $ ( 1.21 )

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	The following tables present information about the Company’s assets and liabilities that are measured at fair value on a recurring basis using the above categories: September 30, 2022 Description Level 1 Level 2 Level 3 Total Assets: Money market mutual funds (1) $ 51,072 $ - $ - $ 51,072 Contingently returnable consideration (2) - - - - Total assets $ 51,072 $ - $ - $ 51,072 December 31, 2021 Description Level 1 Level 2 Level 3 Total Assets: Money market mutual funds (1) $ 24,150 $ - $ - $ 24,150 Available-for-sale securities - 37,049 - 37,049 Contingently returnable consideration (2) - - 879 879 Total assets $ 24,150 $ 37,049 $ 879 $ 62,078 Liabilities: Contingent consideration (2) $ - $ - $ 675 $ 675 Total liabilities $ - $ - $ 675 $ 675 (1) Money market mutual funds are classified as cash equivalents in the Company’s consolidated balance sheets, as short-term, highly liquid investments readily convertible to known amounts of cash, with remaining maturities of three months or less at the time of purchase. The Company’s cash equivalent money market funds have carrying values that approximate fair value. (2) During the year ended December 31, 2021, the Company recorded contingently returnable consideration and contingent consideration as a result of its acquisition of Tango Health. See discussion of valuation techniques and significant assumptions used in determining the fair value of these items in Note 3.
Assets Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis using the above categories: 2022 Balance of contingently returnable consideration at January 1 $ 879 Change in fair value 719 Cash consideration transferred ( 1,598 ) Balance of contingently returnable consideration at September 30 $ -

Marketable Securities (Tables)

Marketable Securities (Tables)	9 Months Ended
	Sep. 30, 2022
Marketable Securities [Abstract]
Schedule of Marketable Securities	Marketable securities consist of corporate bonds, commercial paper and U.S. Treasury and agency bonds. There were no marketable securities as of September 30, 2022 . All marketable securities had contractual maturities of less than one year as of December 31, 2021. The following table presents information about the Company’s marketable securities by major security type: As of December 31, 2021 Sector Amortized cost Allowance for credit losses Net carrying amount Gross unrealized gains Gross unrealized losses Fair value Financial 37,049 - 37,049 - - 37,049 Total $ 37,049 $ - $ 37,049 $ - $ - $ 37,049

Accounts receivable, Net (Table

Accounts receivable, Net (Tables)	9 Months Ended
	Sep. 30, 2022
Accounts Receivable Net [Abstract]
Summary of Account Receivable, Net	Accounts receivable, net include: As of As of Accounts receivable $ 29,578 $ 18,970 Less: Allowance for credit losses ( 115 ) ( 167 ) Less: Allowance for returns ( 1,865 ) ( 2,312 ) Total accounts receivable, net $ 27,598 $ 16,491
Allowance for Credit Losses	Nine Months Ended September 30, Allowance for credit losses 2022 2021 Beginning of period $ 167 $ 200 Provision for credit losses 20 18 Write-offs and recoveries ( 72 ) ( 26 ) End of period $ 115 $ 192

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Convertible Notes	The Notes consist of the following: As of September 30, 2022 December 31, 2021 Liability component: Principal $ 6,888 $ 121,069 Less: Debt discount, net of amortization (1) ( 52 ) ( 13,788 ) Net carrying amount $ 6,836 $ 107,281 Equity component (prior to adoption of ASU 2020-06) (2) - 52,973 Remaining discount amortization period (in years) 1.21 (1) As discussed in Note 2, the Company adopted ASU 2020-06 under the modified retrospective approach effective January 1, 2022. The result was a significant reduction in the recorded debt discount and the related amortization expense. (2) Recorded in the consolidated balance sheet within additional paid-in capital, net of $ 1,550 transaction costs in equity. The remaining balance of these transaction costs was $ 432 as of December 31, 2021.
Summary of Recognized Interest Expense	The following table sets forth total interest expense recognized related to the Notes: Three Months Ended September 30, Nine Months Ended September 30, Interest expense 2022 2021 2022 2021 1.25% coupon $ 259 $ 656 $ 1,016 $ 2,039 Amortization of debt discount and transaction costs (1) 130 2,811 507 8,591 Total interest expense $ 389 $ 3,467 $ 1,523 $ 10,630 _________________ As discussed in Note 2, the Company adopted ASU 2020-06 under the modified retrospective approach effective January 1, 2022. The result was a significant reduction in the recorded debt discount and the related amortization expense.
Schedule of Fair Value and Carrying Value of Convertible Senior Notes	As of September 30, 2022, the fair value of the Notes, which was determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, quoted price of the Notes in an over-the-counter market (Level 2), and carrying value of debt instruments (carrying value excludes the equity component of the Company’s Notes classified in equity prior to the adoption of ASU 2020-06 on January 1, 2022 as discussed in Note 2) were as follows: September 30, 2022 December 31, 2021 Fair Value Carrying Value (1) Fair Value Carrying Value Convertible senior notes $ 6,199 $ 6,836 $ 113,805 $ 107,281 As discussed in Note 2, the Company adopted ASU 2020-06 under the modified retrospective approach effective January 1, 2022 resulting in a $ 12,304 net increase in the carrying value of the Notes.

Long-term Debt (Tables)

Long-term Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Aggregate Amount of Term Facility Principal Payments	As of September 30, 2022, the aggregate amount of the Term Facility principal payments was as follows: Aggregate Principal Payment Years Ending December 31, 2022 - remaining $ 1,400 2023 5,600 2024 7,000 2025 8,400 2026 89,600 Total required principal payments $ 112,000

Commitments (Tables)

Commitments (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Schedule of Supplemental Cash Flow Information Related to Operating and Finance Leases	Supplemental cash flow information related to the Company’s operating and finance leases was as follows: Nine Months Ended September 30, Cash Paid for Amounts Included in the Measurement of Lease Liabilities 2022 2021 Financing cash flows from finance leases $ 5,686 $ 3,902 Operating cash flows from finance leases $ 5,151 $ 2,598 Operating cash flows from operating leases $ 359 $ 362 ROU Assets Obtained in Exchange for New Lease Obligations Finance lease liabilities $ - $ 478

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Shares of Common Stock Reserved for Future Issuance	At September 30, 2022, the Company had reserved a total of 13,335,298 of its authorized 95,000,000 shares of common stock for future issuance as follows: Outstanding stock options 88,000 Restricted stock units 4,432,216 Available for future issuance under stock award plans 3,410,734 Available for future issuance under ESPP 71,014 Issuable upon conversion of Series A Preferred Stock 5,333,334 Total common shares reserved for future issuance 13,335,298

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue From Contract With Customer [Abstract]
Summary of Disaggregation of Revenue by Service Line with Reportable Segments	The following table provide information about disaggregation of revenue by service line: Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Service line: Subscription $ 41,248 $ 44,790 $ 126,320 $ 134,716 Platform 5,643 6,157 18,786 19,801 Total software services $ 46,891 $ 50,947 $ 145,106 $ 154,517 Professional services 9,299 11,079 28,896 33,476 Total $ 56,190 $ 62,026 $ 174,002 $ 187,993
Summary of Contract Assets and Contract Liabilities	The following table provides information about contract assets and contract liabilities from contracts with customers: Balance at Beginning of Period Balance at End of Period Nine Months Ended September 30, 2022 Contract assets $ 18,051 $ 9,357 Contract liabilities Deferred revenue $ 30,133 $ 32,807 Nine Months Ended September 30, 2021 Contract assets $ 15,105 $ 7,076 Contract liabilities Deferred revenue $ 32,204 $ 28,764

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail)	1 Months Ended			3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 31, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jan. 31, 2021 USD ($)	Sep. 30, 2022 USD ($) Customer	Sep. 30, 2021 USD ($) Customer	Sep. 30, 2022 USD ($) Customer	Sep. 30, 2021 USD ($) Customer	Dec. 31, 2021 USD ($) Customer	Jun. 30, 2022 USD ($)
Summary Of Significant Accounting Policies [Line Items]
Restructuring costs				$ 0	$ 0	$ 1,006,000	$ 4,127,000
Contract cost payments, description						The Company capitalizes costs to obtain contracts that are considered incremental and recoverable, such as sales commissions. Payments of sales commissions generally include multiple payments. The Company capitalizes only those payments made within an insignificant time from the contract inception, typically three months or less. Subsequent payments are expensed as incurred. The capitalized costs are amortized to sales and marketing expense over the estimated period of benefit of the asset, which is generally four to five years. The Company expenses the costs to obtain a contract when the amortization period is less than one year.
Restricted cash								$ 0
Insurance recovery									$ 9,240,000
Retained Earnings (Accumulated Deficit)				488,982,000		$ 488,982,000		$ 508,224,000
Equity component of convertible notes					$ (3,566,000)
Convertible Debt
Summary Of Significant Accounting Policies [Line Items]
Retained Earnings (Accumulated Deficit)				(40,669,000)		(40,669,000)
Equity component of convertible notes						52,973,000
Unamortized discount to convertible senior notes				$ 12,304,000		12,304,000
Prior interest expense reversed and recorded to retained earnings						$ 40,669,000
Capitalized Software Development Costs
Summary Of Significant Accounting Policies [Line Items]
Useful lives for property and equipment						3 years
Customer Concentration Risk | Accounts Receivable
Summary Of Significant Accounting Policies [Line Items]
No of Customer | Customer				0		0		0
Customer Concentration Risk | Accounts Receivable | Employer Group
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage						10%		10%
Customer Concentration Risk | Total Revenue
Summary Of Significant Accounting Policies [Line Items]
No of Customer | Customer				0	0	0	0
Customer Concentration Risk | Total Revenue | Employer Group
Summary Of Significant Accounting Policies [Line Items]
Concentration Risk, Percentage				10%	10%	10%	10%
Cost of Revenue
Summary Of Significant Accounting Policies [Line Items]
Estimated amortization period of contract costs						5 years
Minimum | Sales and Marketing Expense
Summary Of Significant Accounting Policies [Line Items]
Estimated amortization period of contract costs						4 years
Maximum
Summary Of Significant Accounting Policies [Line Items]
Cash equivalents maturity period						3 months
Maximum | Sales and Marketing Expense
Summary Of Significant Accounting Policies [Line Items]
Estimated amortization period of contract costs						5 years
UNITED STATES
Summary Of Significant Accounting Policies [Line Items]
Restructuring costs	$ 1,006,000	$ 2,727,000	$ 1,400,000

Schedule of Deferred Contract C

Schedule of Deferred Contract Costs (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Condensed Income Statements Captions [Line Items]
Deferred contract costs and other non-current assets	$ 6,744		$ 6,744		$ 8,864
Sales and Marketing Expense
Condensed Income Statements Captions [Line Items]
Deferred contract costs and other non-current assets	3,190		3,190		4,418
Costs to obtain contracts included in sales and marketing expense	593	$ 753	1,836	$ 2,276
Cost of Revenue
Condensed Income Statements Captions [Line Items]
Deferred contract costs and other non-current assets	1,678		1,678		$ 2,887
Costs to obtain contracts included in sales and marketing expense	$ 207	$ 308	$ 686	$ 998

Schedule of Capitalized Softwar

Schedule of Capitalized Software Development Costs (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Accounting Policies [Abstract]
Capitalized	$ 2,129	$ 1,886	$ 5,614	$ 5,625
Amortized	2,461	$ 2,268	7,280	$ 6,589
Net book value	$ 14,626		$ 14,626		$ 16,292

Business Combination - Addition

Business Combination - Additional Information (Detail) - USD ($)		1 Months Ended	3 Months Ended				9 Months Ended
	Nov. 19, 2021	Apr. 30, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill			$ 34,237,000				$ 34,237,000		$ 34,237,000
Contingent consideration fair value adjustment			$ 0			$ 0	$ 719,000	$ 0
Tango Health, Inc.
Business Acquisition [Line Items]
Purchase price	100%
Business combination, consideration transferred, other	$ 28,471,000	$ 675,000
Goodwill	$ 21,380,000
Identifiable intangible assets acquired, Weighted average amortization period	6 years 10 months 24 days
Contingent liabilities	$ 0
Consideration payable transferred	500,000				$ 500,000
Tango Health, Inc. | Level 3
Business Acquisition [Line Items]
Contingent consideration fair value adjustment				$ 719,000
Contingently returnable consideration	$ 1,598,000

Summary of Fair Value of Consid

Summary of Fair Value of Consideration Paid and Amounts of Assets Acquired and Liabilities Assumed Recognized at Acquisition Date (Detail) - USD ($) $ in Thousands		3 Months Ended
	Nov. 19, 2021	Mar. 31, 2022	Sep. 30, 2022	Dec. 31, 2021
Recognized Amounts of Identifiable Assets Acquired and Liabilities Assumed
Goodwill			$ 34,237	$ 34,237
Tango Health, Inc.
Consideration Transferred
Cash consideration transferred	$ 31,628
Contingently returnable consideration	(879)
Consideration payable	500	$ 500
Contingent consideration	675
Fair value of total purchase price consideration	31,924
Cash acquired	(3,453)
Fair value of total purchase price consideration, net of cash acquired	28,471
Recognized Amounts of Identifiable Assets Acquired and Liabilities Assumed
Accounts receivable, net	2,866
Contract, prepaid and other current assets	453
Intangible assets	13,250
Accounts payable and accrued expenses	(435)
Deferred revenue, current portion	(5,849)
Deferred tax liability	(3,194)
Total identifiable net assets	7,091
Goodwill	21,380
Total identifiable net assets and goodwill	$ 28,471

Common Share Equivalents Securi

Common Share Equivalents Securities Excluded from Calculation of Weighted Average Common Share Outstanding (Detail) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	9,989,612	11,354,253	9,989,612	11,354,253
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	4,432,216	3,642,298	4,432,216	3,642,298
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	88,000	97,553	88,000	97,553
Convertible Debt
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	129,546	2,277,017	129,546	2,277,017
Conversion of Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	5,333,334	5,333,334	5,333,334	5,333,334
Employee Stock Purchase Plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive common share equivalents	6,516	4,051	6,516	4,051

Basic and Diluted Net Loss per

Basic and Diluted Net Loss per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net loss	$ (6,986)	$ (12,164)	$ (2,277)	$ (18,054)	$ (15,020)	$ (2,097)	$ (21,427)	$ (35,171)
Preferred dividends	(1,600)			(1,600)			(4,800)	(4,800)
Net loss available to common stockholders	$ (8,586)			$ (19,654)			$ (26,227)	$ (39,971)
Denominator:
Weighted-average common shares outstanding, basic	34,279,464			33,354,624			33,937,778	32,978,394
Weighted-average common shares outstanding, diluted	34,279,464			33,354,624			33,937,778	32,978,394
Net loss per common share, basic	$ (0.25)			$ (0.59)			$ (0.77)	$ (1.21)
Net loss per common share, diluted	$ (0.25)			$ (0.59)			$ (0.77)	$ (1.21)

Assets and Liabilities Measured

Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - USD ($) $ in Thousands		Sep. 30, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities			$ 37,049
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets		$ 51,072	62,078
Total liabilities			675
Fair Value, Measurements, Recurring | Money market mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market mutual funds	[1]	51,072	24,150
Fair Value, Measurements, Recurring | Available-for-sale securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities			37,049
Fair Value, Measurements, Recurring | Contingently returnable consideration
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingently returnable consideration	[2]	0	879
Fair Value, Measurements, Recurring | Contingent consideration
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	[2]		675
Fair Value, Measurements, Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets		51,072	24,150
Total liabilities			0
Fair Value, Measurements, Recurring | Level 1 | Money market mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market mutual funds	[1]	51,072	24,150
Fair Value, Measurements, Recurring | Level 1 | Available-for-sale securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities			0
Fair Value, Measurements, Recurring | Level 1 | Contingently returnable consideration
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingently returnable consideration	[2]	0	0
Fair Value, Measurements, Recurring | Level 1 | Contingent consideration
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	[2]		0
Fair Value, Measurements, Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets		0	37,049
Total liabilities			0
Fair Value, Measurements, Recurring | Level 2 | Money market mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market mutual funds	[1]	0	0
Fair Value, Measurements, Recurring | Level 2 | Available-for-sale securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities			37,049
Fair Value, Measurements, Recurring | Level 2 | Contingently returnable consideration
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingently returnable consideration	[2]	0	0
Fair Value, Measurements, Recurring | Level 2 | Contingent consideration
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	[2]		0
Fair Value, Measurements, Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets		0	879
Total liabilities			675
Fair Value, Measurements, Recurring | Level 3 | Money market mutual funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Money market mutual funds	[1]	0	0
Fair Value, Measurements, Recurring | Level 3 | Available-for-sale securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities			0
Fair Value, Measurements, Recurring | Level 3 | Contingently returnable consideration
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingently returnable consideration	[2]	$ 0	879
Fair Value, Measurements, Recurring | Level 3 | Contingent consideration
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	[2]		$ 675
[1] Money market mutual funds are classified as cash equivalents in the Company’s consolidated balance sheets, as short-term, highly liquid investments readily convertible to known amounts of cash, with remaining maturities of three months or less at the time of purchase. The Company’s cash equivalent money market funds have carrying values that approximate fair value. During the year ended December 31, 2021, the Company recorded contingently returnable consideration and contingent consideration as a result of its acquisition of Tango Health. See discussion of valuation techniques and significant assumptions used in determining the fair value of these items in Note 3.

Assets Measured at Fair Value o

Assets Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Detail) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Change in fair value		$ 0	$ 0	$ 719	$ 0
Fair Value, Measurements, Recurring | Contingently returnable consideration
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Contingently returnable consideration	[1]			879
Contingently returnable consideration	[1]	0		0
Fair Value, Measurements, Recurring | Contingently returnable consideration | Level 3
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Contingently returnable consideration	[1]			879
Change in fair value				719
Cash consideration transferred				(1,598)
Contingently returnable consideration	[1]	$ 0		$ 0
[1] During the year ended December 31, 2021, the Company recorded contingently returnable consideration and contingent consideration as a result of its acquisition of Tango Health. See discussion of valuation techniques and significant assumptions used in determining the fair value of these items in Note 3.

Marketable Securities - Additio

Marketable Securities - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2021	Sep. 30, 2022
Marketable Securities [Line Items]
Marketable securities	$ 37,049,000	$ 0
Maximum
Marketable Securities [Line Items]
Marketable securities contractual maturity	1 year

Schedule of Marketable Securiti

Schedule of Marketable Securities (Detail)	Dec. 31, 2021 USD ($)
Marketable Securities [Line Items]
Available-for-sale securities	$ 37,049,000
Allowance for credit losses	0
Net carrying amount	37,049,000
Gross unrealized gains	0
Gross unrealized losses	0
Fair value	37,049,000
Financial
Marketable Securities [Line Items]
Available-for-sale securities	37,049,000
Allowance for credit losses	0
Net carrying amount	37,049,000
Gross unrealized gains	0
Gross unrealized losses	0
Fair value	$ 37,049,000

Summary of Account Receivable,

Summary of Account Receivable, Net (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Accounts Receivable Net [Abstract]
Accounts receivable	$ 29,578	$ 18,970
Less: Allowance for credit losses	(115)	(167)	$ (192)	$ (200)
Less: Allowance for returns	(1,865)	(2,312)
Total accounts receivable, net	$ 27,598	$ 16,491

Schedule of Allowance for Credi

Schedule of Allowance for Credit Losses (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Accounts Receivable Net [Abstract]
Beginning of period	$ 167	$ 200
Provision for credit losses	20	18
Write-offs and recoveries	(72)	(26)
End of period	$ 115	$ 192

Convertible Senior Notes - Addi

Convertible Senior Notes - Additional Information (Detail)	1 Months Ended		3 Months Ended	9 Months Ended		12 Months Ended
	Aug. 31, 2022 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) Days $ / shares	Sep. 30, 2021 USD ($)	Dec. 31, 2018 USD ($) shares $ / shares
Debt Instrument [Line Items]
Gain (loss) on extinguishment of debt				$ 1,930,000	$ (7,520,000)
Common Stock
Debt Instrument [Line Items]
Closing price of our common stock | $ / shares				$ 6.35
1.25% Convertible Senior Notes
Debt Instrument [Line Items]
Debt instrument, aggregate principal amount				$ 240,000,000		$ 240,000,000
Debt instrument, interest rate						1.25%
Debt instrument, maturity date						Dec. 15, 2023
Initial effective conversion price of debt instrument | $ / shares				$ 1
Consecutive trading period | Days				5
Interest rate conversion notes				7.30%
Fair value of the liability conversion notes				$ 181,500
Gross proceeds received from issuance of the notes				240,000,000
Difference between gross proceeds received from issuance of the notes and estimated fair value of notes				58,500,000
Transaction costs attributable to the liability component				4,808,000
Transaction costs attributable to the equity component				$ 1,550,000
Debt instrument purchased, aggregate principal amount	$ 114,181,000	$ 100,181,000	$ 100,181,000		100,181,000
Debt instrument repurchased, carrying value	113,557,000	87,592,000	87,592,000		$ 87,592,000
Payment made in cash on purchase of debt	111,627,000	98,678,000
Gain (loss) on extinguishment of debt	1,930,000	(7,520,000)
Payment allocated to broker	$ 571,000	501,000
Payment allocated to liability component of notes		95,113,000
Payment allocated to equity component of notes		$ 3,566,000
1.25% Convertible Senior Notes | Call Option
Debt Instrument [Line Items]
Initial strike price | $ / shares				53.17
Cap price | $ / shares				89.98
Purchase of convertible note capped call hedge				$ 33,024,000
Repayment to terminated transaction			$ 98,000
1.25% Convertible Senior Notes | Maximum
Debt Instrument [Line Items]
Conversion price percentage				1.30
Percent of Senior notes Principal amount to trigger Conversion as product of stock price and conversion rate				98%
1.25% Convertible Senior Notes | Common Stock
Debt Instrument [Line Items]
Debt instrument, conversion ratio						18.8076
Initial effective conversion price of debt instrument | $ / shares						$ 53.17
Number shares issuable upon conversion | shares						4,513,824

Schedule of Convertible Notes (

Schedule of Convertible Notes (Detail) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Equity component of convertible notes	$ (3,566)
1.25% Convertible Senior Notes
Debt Instrument [Line Items]
Principal		$ 6,888	$ 121,069
Less: Debt discount, net of amortization(1)		(52)	(13,788)
Net carrying amount		6,836	107,281
Equity component of convertible notes		$ 0	$ 52,973
Remaining discount amortization period (in years)		1 year 2 months 15 days

Schedule of Convertible Notes_2

Schedule of Convertible Notes (Parenthetical) (Detail) - 1.25% Convertible Senior Notes $ in Thousands	Sep. 30, 2022 USD ($)
Debt Instrument [Line Items]
Transaction costs attributable to the equity component	$ 1,550
Remaining balance of transaction costs	432
Additional Paid-in Capital
Debt Instrument [Line Items]
Transaction costs attributable to the equity component	$ 1,550

Summary of Recognized Interest

Summary of Recognized Interest Expense (Detail) - 1.25% Convertible Senior Notes - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
1.25% coupon	$ 259	$ 656	$ 1,016	$ 2,039
Amortization of debt discount and transaction costs(1)	130	2,811	507	8,591
Total interest expense	$ 389	$ 3,467	$ 1,523	$ 10,630

Schedule of Fair Value and Carr

Schedule of Fair Value and Carrying Value of Convertible Senior Notes (Detail) - 1.25% Convertible Senior Notes - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Fair Value	$ 6,199	$ 113,805
Carrying Value	$ 6,836	$ 107,281

Schedule of Fair Value and Ca_2

Schedule of Fair Value and Carrying Value of Convertible Senior Notes (Parenthetical) (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
1.25% Convertible Senior Notes | ASU 2020-06
Debt Instrument [Line Items]
Increase in carrying value of convertible senior notes	$ 12,304

Long-term Debt - Additional Inf

Long-term Debt - Additional Information (Details) - USD ($)		1 Months Ended	3 Months Ended	9 Months Ended
	Aug. 17, 2022	Aug. 31, 2022	Sep. 30, 2022	Sep. 30, 2022
Revolving Credit Facility
Line Of Credit Facility [Line Items]
Credit facility amount	$ 15,000,000
Borrowings available to be drawn under credit facility			$ 15,000,000	$ 15,000,000
Interest rate at period end			5.56%	5.56%
Amount borrowed under the facility			$ 0	$ 0
Revolving Credit Facility | Minimum | SOFR Priced Loans
Line Of Credit Facility [Line Items]
Interest rate	2%
Revolving Credit Facility | Minimum | ABR Priced Loans
Line Of Credit Facility [Line Items]
Interest rate	1%
Revolving Credit Facility | Maximum
Line Of Credit Facility [Line Items]
Borrowings available to be drawn under credit facility	$ 5,000,000
Revolving Credit Facility | Maximum | SOFR Priced Loans
Line Of Credit Facility [Line Items]
Interest rate	3.25%
Revolving Credit Facility | Maximum | ABR Priced Loans
Line Of Credit Facility [Line Items]
Interest rate	2.25%
Standby Letters of Credit
Line Of Credit Facility [Line Items]
Credit facility amount	$ 10,000,000
Swingline Loans
Line Of Credit Facility [Line Items]
Credit facility amount	10,000,000
Delayed Draw Term Loan Facility
Line Of Credit Facility [Line Items]
Credit facility amount	$ 125,000,000
Borrowings available to be drawn under credit facility			$ 13,000,000	$ 13,000,000
Interest rate at period end			5.56%	5.56%
Amount borrowed under the facility		$ 112,000,000		$ 112,000,000
Delayed Draw Term Loan Facility | Minimum
Line Of Credit Facility [Line Items]
Percentage of aggregate principal amount	1.25%
Borrowings available to be drawn under credit facility	$ 50,000,000
Line of credit facility, commitment fee percentage	0.20%
Delayed Draw Term Loan Facility | Minimum | SOFR Priced Loans
Line Of Credit Facility [Line Items]
Interest rate	2%
Delayed Draw Term Loan Facility | Minimum | ABR Priced Loans
Line Of Credit Facility [Line Items]
Interest rate	1%
Delayed Draw Term Loan Facility | Maximum
Line Of Credit Facility [Line Items]
Percentage of aggregate principal amount	1.875%
Borrowings available to be drawn under credit facility	$ 5,000,000
Line of credit facility, commitment fee percentage	0.40%
Delayed Draw Term Loan Facility | Maximum | SOFR Priced Loans
Line Of Credit Facility [Line Items]
Interest rate	3.25%
Delayed Draw Term Loan Facility | Maximum | ABR Priced Loans
Line Of Credit Facility [Line Items]
Interest rate	2.25%

Long-term Debt - Schedule of Ag

Long-term Debt - Schedule of Aggregate Amount of Term Facility Principal Payments (Details) - Delayed Draw Term Loan Facility $ in Thousands	Sep. 30, 2022 USD ($)
Line Of Credit Facility [Line Items]
2022 - remaining	$ 1,400
2023	5,600
2024	7,000
2025	8,400
2026	89,600
Net carrying amount	$ 112,000

Revolving Line of Credit - Addi

Revolving Line of Credit - Additional Information (Detail) - Revolving Line of Credit Agreement - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Aug. 17, 2022	Mar. 03, 2020
Line Of Credit Facility [Line Items]
Line of credit facility current maximum borrowing capacity			$ 15,000
Payments on revolving line of credit	$ 0	$ 0
Silicon Valley Bank
Line Of Credit Facility [Line Items]
Line of credit facility current maximum borrowing capacity				$ 50,000
Line of credit facility expanded maximum borrowing capacity				$ 100,000

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Information Related to Operating and Finance Leases (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Paid for Amounts Included in the Measurement of Lease Liabilities
Financing cash flows from finance leases	$ 5,686	$ 3,902
Operating cash flows from finance leases	5,151	2,598
Operating cash flows from operating leases	359	362
Finance lease liabilities	$ 0	$ 478

Commitments - Additional Inform

Commitments - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Commitments And Contingencies Disclosure [Abstract]
Extended leases, expiration date	May 31, 2028	May 31, 2028
Finance lease, impairment loss	$ 0	$ 0	$ 1,769	$ 4,003

Redeemable Preferred Stock - Ad

Redeemable Preferred Stock - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended	9 Months Ended
	Jun. 04, 2020	Jun. 30, 2020	Sep. 30, 2022	Dec. 31, 2021
Schedule Of Stockholders Equity [Line Items]
Preferred stock, shares issued			1,777,778	1,777,778
Preferred stock, par value	$ 45
Preferred stock,dividend rate		8%
Preferred stock,initial stated value	105%
Shares will beneficially own in excess of shares of Common Stock outstanding.	19.90%
Common stock shares ownership	19.90%
Percentage of hold shares of preferred stock originally purchased.	10%
Preferred Stock
Schedule Of Stockholders Equity [Line Items]
Buyer and its affiliates descriptions	For so long as the Buyer and its affiliates collectively hold at least 60% of the shares of the Preferred Stock originally purchased by it or the common stock issuable upon conversion thereof, the Company will pay the Buyer a fee of $400 for the first year following closing and $200 per year thereafter. These management and oversight fees are expensed over the period incurred.
Minimum holding percentage of preferred stock			60%
Conversion of stock, amount fee			$ 400
Conversion of stock amount, thereafter			$ 200
Issuance costs related to sale of stock	$ 807
Additional reimbursed reasonable fees	$ 150
Maximum
Schedule Of Stockholders Equity [Line Items]
Preferred stock,originally issued remain outstanding	60%
Series A Preferred Stock
Schedule Of Stockholders Equity [Line Items]
Preferred stock, shares issued	1,777,778
Preferred stock, par value	$ 0.001
Preferred stock,purchase price per share	$ 45
Total gross proceeds	$ 80,000
Preferred stock shares converted into common stock shares			5,333,334
Conversion of Preferred Stock
Schedule Of Stockholders Equity [Line Items]
Initial effective conversion price of debt instrument	$ 15
Preferred stock shares converted into common stock shares	5,333,334

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($) shares
Restricted Stock Units (RSUs)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of restricted stock units, granted | shares	2,028,433
Restricted stock units, aggregate grant date fair value	$ 22,712
Stock plan vesting period	3 years 10 months 6 days
Restricted Stock Units (RSUs) | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock plan vesting period	3 years
Restricted Stock Units (RSUs) | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock plan vesting period	4 years
Performance Based Restricted Stock Units RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of restricted stock units, granted | shares	931,292
Restricted stock units, aggregate grant date fair value	$ 11,227
Stock plan vesting period	3 years 3 months 3 days
Restricted stock units, aggregate grant date fair value assuming target achievement	$ 8,436
Performance Based Restricted Stock Units RSUs | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock plan vesting period	1 year
Shares issued vesting percentage	0%
Performance Based Restricted Stock Units RSUs | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock plan vesting period	4 years
Shares issued vesting percentage	100%

Stockholders' Deficit - Additio

Stockholders' Deficit - Additional Information (Detail) - shares	Sep. 30, 2022	Dec. 31, 2021
Stockholders Equity Note [Abstract]
Common stock, authorized shares reserved for future issuance	13,335,298
Common stock, shares authorized	95,000,000	95,000,000

Common Stock for Future Issuanc

Common Stock for Future Issuance (Detail)	Sep. 30, 2022 shares
Class Of Stock [Line Items]
Outstanding stock options	88,000
Restricted stock units	4,432,216
Total common shares reserved for future issuance	13,335,298
Series A Preferred Stock
Class Of Stock [Line Items]
Preferred stock shares converted into common stock shares	5,333,334
Stock Award Plans
Class Of Stock [Line Items]
Common stock available for future issuance	3,410,734
ESPP
Class Of Stock [Line Items]
Common stock available for future issuance	71,014

Summary of Disaggregation of Re

Summary of Disaggregation of Revenue by Service Line with Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation Of Revenue [Line Items]
Revenue	$ 56,190	$ 62,026	$ 174,002	$ 187,993
Subscription
Disaggregation Of Revenue [Line Items]
Revenue	41,248	44,790	126,320	134,716
Platform
Disaggregation Of Revenue [Line Items]
Revenue	5,643	6,157	18,786	19,801
Total Software Services
Disaggregation Of Revenue [Line Items]
Revenue	46,891	50,947	145,106	154,517
Professional Services
Disaggregation Of Revenue [Line Items]
Revenue	$ 9,299	$ 11,079	$ 28,896	$ 33,476

Summary of Contract Assets and

Summary of Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Revenue From Contract With Customer [Abstract]
Contract assets	$ 9,357	$ 18,051	$ 7,076	$ 15,105
Contract liabilities
Deferred revenue	$ 32,807	$ 30,133	$ 28,764	$ 32,204

Revenue - Additional Informatio

Revenue - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue From Contract With Customer [Abstract]
Asset impairment charges related to contract assets	$ 0	$ 0	$ 0	$ 0
Changes in the contract assets outside of standard revenue and billing activity	0		0
Revenue recognized included in deferred revenue beginning balance	12,835,000		26,734,000
Favorable adjustments to revenue arising from performance obligations satisfied or partially satisfied in previous periods	0		0
Aggregate amount of unsatisfied or partially unsatisfied performance obligations	$ 221,795,000		$ 221,795,000

Revenue - Additional Informat_2

Revenue - Additional Information (Detail1)	Sep. 30, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-10-01
Disaggregation Of Revenue [Line Items]
Performance obligations expected satisfaction period	3 years

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2022
Income Taxes [Line Items]
Percentage of taxable income on utilization of net operating loss in indefinite life period	80%
Maximum
Income Taxes [Line Items]
Effective tax rate	2%

Segments Information - Addition

Segments Information - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2022 Segment
Segment Reporting [Abstract]
Number of Operating Segments	1

Related Parties - Additional In

Related Parties - Additional Information (Detail) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended						9 Months Ended
	Jun. 04, 2020	Apr. 30, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Related Party Transaction [Line Items]
Dividends on preferred stock			$ 1,600	$ 1,600	$ 1,600	$ 1,600	$ 1,600	$ 1,600
Reimbursement for agreed upon fees and expenses, including legal expenses		$ 600
Series A Preferred Stock
Related Party Transaction [Line Items]
Issuance of series A preferred stock for cash, net of issuance costs (in shares)	1,777,778
Dividends on preferred stock			1,600			$ 1,600			$ 4,800	$ 4,800
Management and oversight fees			50						150	$ 186
Due to related party, current			$ 0						$ 0		$ 0

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - Subsequent Event - Voya Merger	Nov. 01, 2022 $ / shares
Voya Merger Agreement
Subsequent Event [Line Items]
Business acquisition, share price	$ 0.50
Support Agreements
Subsequent Event [Line Items]
Business acquisition, percentage of voting interests acquired	24%